CNA Financial Q3 2026 earnings fall to $196M
Third-quarter long-term-care assumption updates added $173 million pretax to the liability for future policy benefits.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
10-Q
CNA Financial Corporation reported third-quarter and nine-month 2026 results, including $3.821 billion of third-quarter revenue and $196 million of net income. Third-quarter revenue was $3.817 billion in 2025, while net income was $403 million; diluted earnings per share were $0.72 versus $1.48. For the first nine months, revenue was $11.327 billion versus $11.161 billion, and net income was $728 million versus $976 million.
Third-quarter immediate net-income charges of $218 million resulted from adverse development in certain long-term-care cohorts where the Net Premium Ratio exceeded 100%; the nine-month amount was $267 million. Third-quarter cash-flow assumption updates increased the liability for future policy benefits by $173 million pretax, with unfavorable cost-of-care inflation and morbidity partly offset by favorable premium-rate actions. Other comprehensive loss was $1.033 billion, including $1.844 billion of net unrealized losses on other investments and an $818 million impact from discount-rate changes on long-duration contract liabilities. Nine-month operating cash flow was $1.696 billion, versus $1.920 billion in 2025; dividends paid to common stockholders were $943 million.
0 points · 0 major0 major · 3 points
How this balance works
Rhea-AI gives every point it takes from this document a weight. Minor counts 1, Moderate 3 and Major 9, so one Major point outweighs several Minor ones. The bar adds up the weights on each side, and when neither side holds more than 65% of the total the balance reads Mixed.
It reads the document as published, with the same rules for every company, and it does not look at what the market expected or at how the stock traded, so a point can be objectively good on a day the stock falls.
Rhea-AI Sentiment measures something else, the tone of the wording.
Positive
- None.
Negative
- Moderate pointNine-month operating cash flow: $1.696 billion, versus $1.920 billion.
- Moderate pointLong-term-care adverse-development charges: $218 million in Q3. 1.7% of market cap
- Minor pointQ3 and nine-month net income: $196 million and $728 million, versus $403 million and $976 million.
Filing Explained
CNA approved pursuing termination of its pension plan, with a June 30, 2026 effective date; the process is not complete; the plan remains reflected in CNA’s financial statements until remaining benefits are settled or transferred, which the company currently anticipates in 2028.
Key Figures
Third-quarter total revenues: $3.821 billion; $3.817 billion in 2025
Third-quarter net income: $196 million; $403 million in 2025
Diluted earnings per share: $0.72 per share; $1.48 per share in 2025
+5 more
8 metrics
Third-quarter total revenues
$3.821 billion; $3.817 billion in 2025
Three months ended September 30
Third-quarter net income
$196 million; $403 million in 2025
Three months ended September 30
Diluted earnings per share
$0.72 per share; $1.48 per share in 2025
Three months ended September 30
Nine-month net income
$728 million; $976 million in 2025
Nine months ended September 30
Net cash flows provided by operating activities
$1.696 billion; $1.920 billion in 2025
Nine months ended September 30
Immediate long-term-care adverse-development charges
$218 million for three months; $267 million for nine months
2026; cohorts where the Net Premium Ratio exceeded 100%
Net liability for future policy benefits
$12.437 billion
As of September 30, 2026
Gross unrealized losses on fixed maturity securities
$4.171 billion
As of September 30, 2026; securities in a gross loss position without an allowance for credit losses
Key Terms
Core income (loss), Underlying combined ratio, Net Premium Ratio (NPR), Loss Portfolio Transfer (LPT), +1 more
5 terms
Core income (loss) financial
"We utilize the core income (loss) financial measure to monitor our operations"
Underlying combined ratio financial
"the underlying combined ratio are deemed to be non-GAAP financial measures"
The underlying combined ratio is an insurer’s core underwriting profit measure: it compares claims paid plus operating costs to premiums earned, after removing one-off or unusual items (like major catastrophe losses, reserve adjustments or accounting timing effects). It matters to investors because it reveals the steady, repeatable strength of an insurer’s business—like a car’s average fuel efficiency when you ignore a single outlier trip—helping separate true performance from temporary noise.
Net Premium Ratio (NPR) financial
"cohorts where the Net Premium Ratio (NPR) exceeded 100%"
Loss Portfolio Transfer (LPT) financial
"under a retroactive reinsurance agreement with an aggregate limit of $4 billion"
Level 3 financial
"valuations derived from valuation techniques in which one or more significant inputs are not observable"
Level 3 describes the lowest-confidence category in the accounting “fair value” hierarchy, covering assets or liabilities whose prices are not observable in the market and must be estimated using judgment and internal models. For investors, Level 3 items matter because they can introduce greater uncertainty and potential valuation swings—like valuing a unique antique versus checking a price tag on a supermarket shelf—so they signal higher model risk and lower liquidity.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
How much did CNA (CNA) earn in Q3 2026?
CNA reported net income of $196 million and diluted earnings per share of $0.72 for the three months ended September 30, 2026, compared with $403 million and $1.48, respectively, in 2025.
What were CNA's first nine-month 2026 revenue and net income?
CNA reported revenue of $11.327 billion and net income of $728 million for the nine months ended September 30, 2026, compared with $11.161 billion and $976 million in 2025.
When does CNA expect to complete its pension plan termination?
A CNA subsidiary, as sponsor of the CNA Retirement Plan, approved the decision to pursue termination effective June 30, 2026. CNA currently anticipates completing the process, including settlement or transfer of remaining benefit obligations, in 2028.
How much were CNA's unrealized losses on fixed maturity securities at September 30, 2026?
CNA reported $4.171 billion of gross unrealized losses on fixed maturity securities in a gross loss position for which no allowance for credit losses had been recorded. CNA said the losses were primarily attributable to changes in risk-free interest rates.
What investment commitments did CNA report at September 30, 2026?
CNA had commitments to purchase or fund approximately $2,085 million and commitments to sell approximately $50 million under the terms of its investments.
AI-generated analysis. How Rhea-AI works. Not financial advice.
See more from StockTitan in Google Search and AI answers.
Adds StockTitan as a preferred source · opens Google
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-Q
| QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 | |||||||||||
For the quarterly period ended September 30, 2026
OR
| TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 | |||||||||||
For the transition period from _____ to _____
Commission File Number 1-5823
(Exact name of registrant as specified in its charter)
| (State or other jurisdiction of incorporation or organization) | (I.R.S. Employer Identification No.) | |||||||
| (Zip Code) | |||||||||||
| (Address of principal executive offices) | |||||||||||
(312 ) 822-5000
(Registrant's telephone number, including area code)
Not Applicable
(Former name, former address and former fiscal year, if changed since last report)
Securities registered pursuant to Section 12(b) of the Act:
| Title of each class | Trading Symbol(s) | Name of each exchange on which registered | ||||||||||||
" | ||||||||||||||
| NYSE Texas | ||||||||||||||
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and "emerging growth company" in Rule 12b-2 of the Exchange Act.
☒ | Accelerated filer | ☐ | Non-accelerated filer | ☐ | Smaller reporting company | Emerging growth company | |||||||||||||||||||||||
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act). Yes ☐ No ☒
As of October 29, 2026, 270,614,393 shares of common stock were outstanding.
| Item Number | Page Number | |||||||
PART I | ||||||||
| 1. | Condensed Consolidated Financial Statements: | 3 | ||||||
Condensed Consolidated Statements of Operations for the three and nine months ended September 30, 2026 and 2025 (Unaudited) | 3 | |||||||
Condensed Consolidated Statements of Comprehensive (Loss) Income for the three and nine months ended September 30, 2026 and 2025 (Unaudited) | 4 | |||||||
Condensed Consolidated Balance Sheets as of September 30, 2026 (Unaudited) and December 31, 2025 | 5 | |||||||
Condensed Consolidated Statements of Cash Flows for the nine months ended September 30, 2026 and 2025 (Unaudited) | 6 | |||||||
Condensed Consolidated Statements of Stockholders' Equity for the three and nine months ended September 30, 2026 and 2025 (Unaudited) | 7 | |||||||
Notes to Condensed Consolidated Financial Statements (Unaudited) | 8 | |||||||
| 2. | Management's Discussion and Analysis of Financial Condition and Results of Operations | 45 | ||||||
| 3. | Quantitative and Qualitative Disclosures About Market Risk | 68 | ||||||
| 4. | Controls and Procedures | 68 | ||||||
PART II | ||||||||
| 1 | Legal Proceedings | 69 | ||||||
| 6 | Exhibits | 69 | ||||||
2
Table of Contents
PART I
Item 1. Condensed Consolidated Financial Statements
CNA Financial Corporation
Condensed Consolidated Statements of Operations (Unaudited)
| Periods ended September 30 | Three Months | Nine Months | |||||||||||||||||||||
| (In millions, except per share data) | 2026 | 2025 | 2026 | 2025 | |||||||||||||||||||
| Revenues | |||||||||||||||||||||||
| Net earned premiums | $ | $ | $ | $ | |||||||||||||||||||
| Net investment income | |||||||||||||||||||||||
| Net investment losses | ( | ( | ( | ( | |||||||||||||||||||
| Non-insurance warranty revenue | |||||||||||||||||||||||
| Other revenues | |||||||||||||||||||||||
| Total revenues | |||||||||||||||||||||||
| Claims, Benefits and Expenses | |||||||||||||||||||||||
Insurance claims and policyholders’ benefits (re-measurement loss of $ | |||||||||||||||||||||||
| Amortization of deferred acquisition costs | |||||||||||||||||||||||
| Non-insurance warranty expense | |||||||||||||||||||||||
| Other operating expenses | |||||||||||||||||||||||
| Interest expense | |||||||||||||||||||||||
| Total claims, benefits and expenses | |||||||||||||||||||||||
| Income before income tax | |||||||||||||||||||||||
| Income tax expense | ( | ( | ( | ( | |||||||||||||||||||
| Net income | $ | $ | $ | $ | |||||||||||||||||||
| Basic earnings per share | $ | $ | $ | $ | |||||||||||||||||||
| Diluted earnings per share | $ | $ | $ | $ | |||||||||||||||||||
| Weighted Average Outstanding Common Stock and Common Stock Equivalents | |||||||||||||||||||||||
| Basic | |||||||||||||||||||||||
| Diluted | |||||||||||||||||||||||
The accompanying Notes are an integral part of these Condensed Consolidated Financial Statements (Unaudited).
3
Table of Contents
CNA Financial Corporation
Condensed Consolidated Statements of Comprehensive (Loss) Income (Unaudited)
| Periods ended September 30 | Three Months | Nine Months | |||||||||||||||||||||
| (In millions) | 2026 | 2025 | 2026 | 2025 | |||||||||||||||||||
| Comprehensive Income | |||||||||||||||||||||||
| Net income | $ | $ | $ | $ | |||||||||||||||||||
| Other Comprehensive (Loss) Income, net of tax | |||||||||||||||||||||||
| Changes in: | |||||||||||||||||||||||
| Net unrealized gains and losses on investments with an allowance for credit losses | ( | ||||||||||||||||||||||
| Net unrealized gains and losses on other investments | ( | ( | |||||||||||||||||||||
| Net unrealized gains and losses on investments | ( | ( | |||||||||||||||||||||
| Impact of changes in discount rates used to measure long-duration contract liabilities | ( | ( | |||||||||||||||||||||
| Foreign currency translation adjustment | ( | ( | ( | ||||||||||||||||||||
| Pension and postretirement benefits | |||||||||||||||||||||||
| Other comprehensive (loss) income, net of tax | ( | ( | |||||||||||||||||||||
| Total comprehensive (loss) income | $ | ( | $ | $ | ( | $ | |||||||||||||||||
The accompanying Notes are an integral part of these Condensed Consolidated Financial Statements (Unaudited).
4
Table of Contents
CNA Financial Corporation
Condensed Consolidated Balance Sheets
| (In millions, except share data) | September 30, 2026 (Unaudited) | December 31, 2025 | |||||||||
| Assets | |||||||||||
| Investments: | |||||||||||
Fixed maturity securities at fair value (amortized cost of $ | $ | $ | |||||||||
Equity securities at fair value (cost of $ | |||||||||||
| Limited partnership investments | |||||||||||
| Other invested assets | |||||||||||
Mortgage loans (less allowance for credit loss of $ | |||||||||||
| Short-term investments | |||||||||||
| Total investments | |||||||||||
| Cash | |||||||||||
Reinsurance receivables (less allowance for uncollectible receivables of $ | |||||||||||
Insurance receivables (less allowance for uncollectible receivables of $ | |||||||||||
| Accrued investment income | |||||||||||
| Deferred acquisition costs | |||||||||||
| Deferred income taxes | |||||||||||
Property and equipment at cost (less accumulated depreciation of $ | |||||||||||
| Goodwill | |||||||||||
| Deferred non-insurance warranty acquisition expense | |||||||||||
| Other assets | |||||||||||
| Total assets | $ | $ | |||||||||
| Liabilities | |||||||||||
| Insurance reserves: | |||||||||||
| Claim and claim adjustment expenses | $ | $ | |||||||||
| Unearned premiums | |||||||||||
| Future policy benefits | |||||||||||
| Short-term debt | |||||||||||
| Long-term debt | |||||||||||
| Deferred non-insurance warranty revenue | |||||||||||
Other liabilities (includes $ | |||||||||||
| Total liabilities | |||||||||||
Commitments and contingencies (Notes C and G) | |||||||||||
| Stockholders' Equity | |||||||||||
Common stock ($ | |||||||||||
| Additional paid-in capital | |||||||||||
| Retained earnings | |||||||||||
| Accumulated other comprehensive loss | ( | ( | |||||||||
Treasury stock ( | ( | ( | |||||||||
| Total stockholders’ equity | |||||||||||
| Total liabilities and stockholders' equity | $ | $ | |||||||||
The accompanying Notes are an integral part of these Condensed Consolidated Financial Statements (Unaudited).
5
Table of Contents
CNA Financial Corporation
Condensed Consolidated Statements of Cash Flows (Unaudited)
| Nine months ended September 30 | |||||||||||
| (In millions) | 2026 | 2025 | |||||||||
| Cash Flows from Operating Activities | |||||||||||
| Net income | $ | $ | |||||||||
| Adjustments to reconcile net income to net cash flows provided by operating activities: | |||||||||||
| Deferred income tax (benefit) expense | ( | ||||||||||
| Trading portfolio activity | ( | ||||||||||
| Net investment losses | |||||||||||
| Equity method investees | ( | ( | |||||||||
| Net amortization of investments | ( | ( | |||||||||
| Depreciation and amortization | |||||||||||
| Changes in: | |||||||||||
| Receivables, net | ( | ( | |||||||||
| Accrued investment income | ( | ( | |||||||||
| Deferred acquisition costs | ( | ( | |||||||||
| Insurance reserves | |||||||||||
| Other, net | ( | ( | |||||||||
| Net cash flows provided by operating activities | |||||||||||
| Cash Flows from Investing Activities | |||||||||||
| Dispositions: | |||||||||||
| Fixed maturity securities - sales | |||||||||||
| Fixed maturity securities - maturities, calls and redemptions | |||||||||||
| Equity securities | |||||||||||
| Limited partnerships | |||||||||||
| Mortgage loans | |||||||||||
| Purchases: | |||||||||||
| Fixed maturity securities | ( | ( | |||||||||
| Equity securities | ( | ( | |||||||||
| Limited partnerships | ( | ( | |||||||||
| Mortgage loans | ( | ( | |||||||||
| Change in other investments | ( | ( | |||||||||
| Change in short-term investments | ( | ||||||||||
| Purchases of property and equipment | ( | ( | |||||||||
| Other, net | |||||||||||
| Net cash flows used by investing activities | ( | ( | |||||||||
| Cash Flows from Financing Activities | |||||||||||
| Dividends paid to common stockholders | ( | ( | |||||||||
| Proceeds from the issuance of debt | |||||||||||
| Purchase of treasury stock | ( | ( | |||||||||
| Other, net | ( | ( | |||||||||
| Net cash flows used by financing activities | ( | ( | |||||||||
| Effect of foreign exchange rate changes on cash | ( | ||||||||||
| Net change in cash | ( | ||||||||||
| Cash, beginning of year | |||||||||||
| Cash, end of period | $ | $ | |||||||||
The accompanying Notes are an integral part of these Condensed Consolidated Financial Statements (Unaudited).
6
Table of Contents
CNA Financial Corporation
Condensed Consolidated Statements of Stockholders' Equity (Unaudited)
| Periods ended September 30 | Three Months | Nine Months | |||||||||||||||||||||
| (In millions) | 2026 | 2025 | 2026 | 2025 | |||||||||||||||||||
| Common Stock | |||||||||||||||||||||||
| Balance, beginning of period | $ | $ | $ | $ | |||||||||||||||||||
| Balance, end of period | |||||||||||||||||||||||
| Additional Paid-in Capital | |||||||||||||||||||||||
| Balance, beginning of period | |||||||||||||||||||||||
| Stock-based compensation | ( | ( | |||||||||||||||||||||
| Balance, end of period | |||||||||||||||||||||||
| Retained Earnings | |||||||||||||||||||||||
| Balance, beginning of period | |||||||||||||||||||||||
Dividends to common stockholders ($ | ( | ( | ( | ( | |||||||||||||||||||
| Net income | |||||||||||||||||||||||
| Balance, end of period | |||||||||||||||||||||||
| Accumulated Other Comprehensive Loss | |||||||||||||||||||||||
| Balance, beginning of period | ( | ( | ( | ( | |||||||||||||||||||
| Other comprehensive (loss) income | ( | ( | |||||||||||||||||||||
| Balance, end of period | ( | ( | ( | ( | |||||||||||||||||||
| Treasury Stock | |||||||||||||||||||||||
| Balance, beginning of period | ( | ( | ( | ( | |||||||||||||||||||
| Stock-based compensation | |||||||||||||||||||||||
| Purchase of treasury stock | ( | ( | |||||||||||||||||||||
| Balance, end of period | ( | ( | ( | ( | |||||||||||||||||||
| Total stockholders' equity | $ | $ | $ | $ | |||||||||||||||||||
The accompanying Notes are an integral part of these Condensed Consolidated Financial Statements (Unaudited).
7
Table of Contents
CNA Financial Corporation
Notes to Condensed Consolidated Financial Statements
Note A. General
Basis of Presentation
The Condensed Consolidated Financial Statements include the accounts of CNA Financial Corporation (CNAF) and its subsidiaries. Collectively, CNAF and its subsidiaries are referred to as CNA or the Company. Loews Corporation (Loews) owned approximately 92 % of the outstanding common stock of CNAF as of September 30, 2026.
The accompanying Condensed Consolidated Financial Statements have been prepared in conformity with accounting principles generally accepted in the United States of America (GAAP). Intercompany amounts have been eliminated. Certain financial information that is normally included in annual financial statements prepared in accordance with GAAP, including certain financial statement notes, is not required for interim reporting purposes and has been condensed or omitted. These statements should be read in conjunction with the Consolidated Financial Statements and notes thereto included in CNAF's Annual Report on Form 10-K filed with the Securities and Exchange Commission (SEC) for the year ended December 31, 2025, including the summary of significant accounting policies in Note A. The preparation of Condensed Consolidated Financial Statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the Condensed Consolidated Financial Statements and the reported amounts of revenues and expenses during the reporting period. Actual results may differ from those estimates.
The interim financial data as of September 30, 2026 and for the three and nine months ended September 30, 2026 and 2025 is unaudited. However, in the opinion of management, the interim data includes all adjustments, including normal recurring adjustments, necessary for a fair statement of the Company's results for the interim periods in accordance with GAAP. The results of operations for the interim periods are not necessarily indicative of the results to be expected for the full year.
Accounting Standards Pending Adoption
8
Table of Contents
Note B. Earnings Per Share Data
Earnings per share is based on weighted average number of outstanding common shares. Basic earnings per share excludes the impact of dilutive securities and is computed by dividing Net income by the weighted average number of common shares outstanding for the period. Diluted earnings per share reflects the potential dilution that could occur if securities or other contracts to issue common stock were exercised or converted into common stock.
The following table presents the income and share data used in the basic and diluted earnings per share computations.
| Periods ended September 30 | Three Months | Nine Months | |||||||||||||||||||||
| (In millions, except per share data) | 2026 | 2025 | 2026 | 2025 | |||||||||||||||||||
| Net income | $ | $ | $ | $ | |||||||||||||||||||
| Common Stock and Common Stock Equivalents | |||||||||||||||||||||||
| Basic | |||||||||||||||||||||||
| Weighted average shares outstanding | |||||||||||||||||||||||
| Diluted | |||||||||||||||||||||||
| Weighted average shares outstanding | |||||||||||||||||||||||
| Dilutive effect of stock-based awards under compensation plans | |||||||||||||||||||||||
| Total | |||||||||||||||||||||||
| Earnings per share | |||||||||||||||||||||||
| Basic | $ | $ | $ | $ | |||||||||||||||||||
| Diluted | $ | $ | $ | $ | |||||||||||||||||||
Excluded from the calculation of diluted earnings per share is the impact of potential shares attributable to exercises or conversions into common stock under stock-based employee compensation plans that would have been antidilutive during the respective periods.
9
Table of Contents
Note C. Investments
The significant components of Net investment income are presented in the following table.
| Periods ended September 30 | Three Months | Nine Months | |||||||||||||||||||||
| (In millions) | 2026 | 2025 | 2026 | 2025 | |||||||||||||||||||
| Fixed maturity securities | $ | $ | $ | $ | |||||||||||||||||||
| Equity securities | |||||||||||||||||||||||
| Limited partnership investments | |||||||||||||||||||||||
| Mortgage loans | |||||||||||||||||||||||
| Short-term investments | |||||||||||||||||||||||
| Trading portfolio | ( | ||||||||||||||||||||||
| Other | |||||||||||||||||||||||
| Gross investment income | |||||||||||||||||||||||
| Investment expense | ( | ( | ( | ( | |||||||||||||||||||
| Net investment income | $ | $ | $ | $ | |||||||||||||||||||
Net investment income (loss) recognized due to the change in fair value of common stock held as of September 30, 2026 and 2025 | $ | $ | $ | $ | |||||||||||||||||||
Net investment gains (losses) are presented in the following table.
| Periods ended September 30 | Three Months | Nine Months | |||||||||||||||||||||
| (In millions) | 2026 | 2025 | 2026 | 2025 | |||||||||||||||||||
| Net investment gains (losses): | |||||||||||||||||||||||
| Fixed maturity securities: | |||||||||||||||||||||||
| Gross gains | $ | $ | $ | $ | |||||||||||||||||||
| Gross losses | ( | ( | ( | ( | |||||||||||||||||||
| Net investment gains (losses) on fixed maturity securities | ( | ( | ( | ||||||||||||||||||||
| Equity securities | ( | ( | |||||||||||||||||||||
| Mortgage loans | ( | ||||||||||||||||||||||
| Short-term investments and other | ( | ( | ( | ||||||||||||||||||||
| Net investment gains (losses) | $ | ( | $ | ( | $ | ( | $ | ( | |||||||||||||||
Net investment gains (losses) recognized due to the change in fair value of non-redeemable preferred stock held as of September 30, 2026 and 2025 | $ | ( | $ | $ | ( | $ | |||||||||||||||||
The available-for-sale impairment losses (gains) recognized in earnings by asset type are presented in the following table. The table includes losses (gains) on securities with an intention to sell and changes in the allowance for credit losses on securities since acquisition date.
| Periods ended September 30 | Three Months | Nine Months | |||||||||||||||||||||
| (In millions) | 2026 | 2025 | 2026 | 2025 | |||||||||||||||||||
| Fixed maturity securities available-for-sale: | |||||||||||||||||||||||
| Corporate and other bonds | $ | $ | $ | $ | |||||||||||||||||||
| Asset-backed | |||||||||||||||||||||||
| Impairment losses (gains) recognized in earnings | $ | $ | $ | $ | |||||||||||||||||||
There were no 5 million of impairment losses on mortgage loans during the nine months ended September 30, 2025 due to changes in expected credit losses.
10
Table of Contents
The following tables present a summary of fixed maturity securities.
| September 30, 2026 | Cost or Amortized Cost | Gross Unrealized Gains | Gross Unrealized Losses | Allowance for Credit Losses | Estimated Fair Value | ||||||||||||||||||||||||
| (In millions) | |||||||||||||||||||||||||||||
| Fixed maturity securities available-for-sale: | |||||||||||||||||||||||||||||
| Corporate and other bonds | $ | $ | $ | $ | $ | ||||||||||||||||||||||||
| States, municipalities and political subdivisions | |||||||||||||||||||||||||||||
| Asset-backed: | |||||||||||||||||||||||||||||
| Residential mortgage-backed | |||||||||||||||||||||||||||||
| Commercial mortgage-backed | |||||||||||||||||||||||||||||
| Other asset-backed | |||||||||||||||||||||||||||||
| Total asset-backed | |||||||||||||||||||||||||||||
| U.S. Treasury and obligations of government-sponsored enterprises | |||||||||||||||||||||||||||||
| Foreign government | |||||||||||||||||||||||||||||
| Redeemable preferred stock | |||||||||||||||||||||||||||||
| Total fixed maturity securities available-for-sale | $ | $ | $ | $ | $ | ||||||||||||||||||||||||
| Total fixed maturity securities | $ | $ | $ | $ | $ | ||||||||||||||||||||||||
| December 31, 2025 | Cost or Amortized Cost | Gross Unrealized Gains | Gross Unrealized Losses | Allowance for Credit Losses | Estimated Fair Value | ||||||||||||||||||||||||
| (In millions) | |||||||||||||||||||||||||||||
| Fixed maturity securities available-for-sale: | |||||||||||||||||||||||||||||
| Corporate and other bonds | $ | $ | $ | $ | $ | ||||||||||||||||||||||||
| States, municipalities and political subdivisions | |||||||||||||||||||||||||||||
| Asset-backed: | |||||||||||||||||||||||||||||
| Residential mortgage-backed | |||||||||||||||||||||||||||||
| Commercial mortgage-backed | |||||||||||||||||||||||||||||
| Other asset-backed | |||||||||||||||||||||||||||||
| Total asset-backed | |||||||||||||||||||||||||||||
| U.S. Treasury and obligations of government-sponsored enterprises | |||||||||||||||||||||||||||||
| Foreign government | |||||||||||||||||||||||||||||
| Redeemable preferred stock | |||||||||||||||||||||||||||||
| Total fixed maturity securities available-for-sale | $ | $ | $ | $ | $ | ||||||||||||||||||||||||
| Total fixed maturity securities | $ | $ | $ | $ | $ | ||||||||||||||||||||||||
11
Table of Contents
The following tables present the estimated fair value and gross unrealized losses of available-for-sale fixed maturity securities in a gross unrealized loss position for which an allowance for credit loss has not been recorded, by the length of time in which the securities have continuously been in that position.
| Less than 12 Months | 12 Months or Longer | Total | |||||||||||||||||||||||||||||||||
| September 30, 2026 | Estimated Fair Value | Gross Unrealized Losses | Estimated Fair Value | Gross Unrealized Losses | Estimated Fair Value | Gross Unrealized Losses | |||||||||||||||||||||||||||||
| (In millions) | |||||||||||||||||||||||||||||||||||
| Fixed maturity securities available-for-sale: | |||||||||||||||||||||||||||||||||||
| Corporate and other bonds | $ | $ | $ | $ | $ | $ | |||||||||||||||||||||||||||||
| States, municipalities and political subdivisions | |||||||||||||||||||||||||||||||||||
| Asset-backed: | |||||||||||||||||||||||||||||||||||
| Residential mortgage-backed | |||||||||||||||||||||||||||||||||||
| Commercial mortgage-backed | |||||||||||||||||||||||||||||||||||
| Other asset-backed | |||||||||||||||||||||||||||||||||||
| Total asset-backed | |||||||||||||||||||||||||||||||||||
| U.S. Treasury and obligations of government-sponsored enterprises | |||||||||||||||||||||||||||||||||||
| Foreign government | |||||||||||||||||||||||||||||||||||
| Total | $ | $ | $ | $ | $ | $ | |||||||||||||||||||||||||||||
| Less than 12 Months | 12 Months or Longer | Total | |||||||||||||||||||||||||||||||||
| December 31, 2025 | Estimated Fair Value | Gross Unrealized Losses | Estimated Fair Value | Gross Unrealized Losses | Estimated Fair Value | Gross Unrealized Losses | |||||||||||||||||||||||||||||
| (In millions) | |||||||||||||||||||||||||||||||||||
| Fixed maturity securities available-for-sale: | |||||||||||||||||||||||||||||||||||
| Corporate and other bonds | $ | $ | $ | $ | $ | $ | |||||||||||||||||||||||||||||
| States, municipalities and political subdivisions | |||||||||||||||||||||||||||||||||||
| Asset-backed: | |||||||||||||||||||||||||||||||||||
| Residential mortgage-backed | |||||||||||||||||||||||||||||||||||
| Commercial mortgage-backed | |||||||||||||||||||||||||||||||||||
| Other asset-backed | |||||||||||||||||||||||||||||||||||
| Total asset-backed | |||||||||||||||||||||||||||||||||||
| U.S. Treasury and obligations of government-sponsored enterprises | |||||||||||||||||||||||||||||||||||
| Foreign government | |||||||||||||||||||||||||||||||||||
| Total | $ | $ | $ | $ | $ | $ | |||||||||||||||||||||||||||||
12
Table of Contents
The following table presents the estimated fair value and gross unrealized losses of available-for-sale fixed maturity securities in a gross unrealized loss position for which an allowance for credit loss has not been recorded, by ratings distribution.
| September 30, 2026 | December 31, 2025 | ||||||||||||||||||||||
(In millions) | Estimated Fair Value | Gross Unrealized Losses | Estimated Fair Value | Gross Unrealized Losses | |||||||||||||||||||
| U.S. Government, Government agencies and Government-sponsored enterprises | $ | $ | $ | $ | |||||||||||||||||||
| AAA | |||||||||||||||||||||||
| AA | |||||||||||||||||||||||
| A | |||||||||||||||||||||||
| BBB | |||||||||||||||||||||||
| Non-investment grade | |||||||||||||||||||||||
| Total | $ | $ | $ | $ | |||||||||||||||||||
Based on current facts and circumstances, the Company believes the unrealized losses presented in the September 30, 2026 securities in a gross unrealized loss position tables above are not indicative of the ultimate collectability of the current amortized cost of the securities, but rather are primarily attributable to changes in risk-free interest rates. In reaching this determination, the Company considered the volatility in risk-free rates and credit spreads as well as the fact that its unrealized losses are concentrated in investment grade issuers. Additionally, the Company has no current intent to sell securities with unrealized losses, nor is it more likely than not that it will be required to sell prior to recovery of amortized cost; accordingly, the Company has determined that there are no additional impairment losses to be recorded as of September 30, 2026.
13
Table of Contents
The following tables present the activity related to the allowance on available-for-sale securities with credit impairments and purchased credit-deteriorated (PCD) assets. Accrued interest receivable on available-for-sale fixed maturity securities totale d $497 million, $470 million and $469 million as of September 30, 2026, December 31, 2025 and September 30, 2025 and is excluded from the estimate of expected credit losses and the amortized cost basis in the tables included within this Note.
| (In millions) | Corporate and other bonds | Asset-backed | Total | ||||||||||||||
| Allowance for credit losses: | |||||||||||||||||
Balance as of July 1, 2026 | $ | $ | $ | ||||||||||||||
| Additions to the allowance for credit losses: | |||||||||||||||||
| Securities for which credit losses were not previously recorded | |||||||||||||||||
| Available-for-sale securities accounted for as PCD assets | |||||||||||||||||
| Reductions to the allowance for credit losses: | |||||||||||||||||
| Intent to sell or more likely than not will be required to sell the security before recovery of its amortized cost basis | |||||||||||||||||
| Additional increases or (decreases) to the allowance for credit losses on securities that had an allowance recorded in a previous period | |||||||||||||||||
Balance as of September 30, 2026 | $ | $ | $ | ||||||||||||||
| (In millions) | Corporate and other bonds | Asset-backed | Total | ||||||||||||||
| Allowance for credit losses: | |||||||||||||||||
Balance as of July 1, 2025 | $ | $ | $ | ||||||||||||||
| Additions to the allowance for credit losses: | |||||||||||||||||
| Securities for which credit losses were not previously recorded | |||||||||||||||||
| Available-for-sale securities accounted for as PCD assets | |||||||||||||||||
| Reductions to the allowance for credit losses: | |||||||||||||||||
| Intent to sell or more likely than not will be required to sell the security before recovery of its amortized cost basis | |||||||||||||||||
| Additional increases or (decreases) to the allowance for credit losses on securities that had an allowance recorded in a previous period | |||||||||||||||||
Balance as of September 30, 2025 | $ | $ | $ | ||||||||||||||
14
Table of Contents
| (In millions) | Corporate and other bonds | Asset-backed | Total | ||||||||||||||
| Allowance for credit losses: | |||||||||||||||||
Balance as of January 1, 2026 | $ | $ | $ | ||||||||||||||
| Additions to the allowance for credit losses: | |||||||||||||||||
| Securities for which credit losses were not previously recorded | |||||||||||||||||
| Available-for-sale securities accounted for as PCD assets | |||||||||||||||||
| Reductions to the allowance for credit losses: | |||||||||||||||||
| Securities disposed during the period (realized) | |||||||||||||||||
| Intent to sell or more likely than not will be required to sell the security before recovery of its amortized cost basis | |||||||||||||||||
| Additional increases or (decreases) to the allowance for credit losses on securities that had an allowance recorded in a previous period | |||||||||||||||||
Balance as of September 30, 2026 | $ | $ | $ | ||||||||||||||
| (In millions) | Corporate and other bonds | Asset-backed | Total | ||||||||||||||
| Allowance for credit losses: | |||||||||||||||||
Balance as of January 1, 2025 | $ | $ | $ | ||||||||||||||
| Additions to the allowance for credit losses: | |||||||||||||||||
| Securities for which credit losses were not previously recorded | |||||||||||||||||
| Available-for-sale securities accounted for as PCD assets | |||||||||||||||||
| Reductions to the allowance for credit losses: | |||||||||||||||||
| Securities disposed during the period (realized) | |||||||||||||||||
| Intent to sell or more likely than not will be required to sell the security before recovery of its amortized cost basis | |||||||||||||||||
| Additional increases or (decreases) to the allowance for credit losses on securities that had an allowance recorded in a previous period | |||||||||||||||||
Balance as of September 30, 2025 | $ | $ | $ | ||||||||||||||
15
Table of Contents
Contractual Maturity
The following table presents available-for-sale fixed maturity securities by contractual maturity.
| September 30, 2026 | December 31, 2025 | ||||||||||||||||||||||
| (In millions) | Cost or Amortized Cost | Estimated Fair Value | Cost or Amortized Cost | Estimated Fair Value | |||||||||||||||||||
| Due in one year or less | $ | $ | $ | $ | |||||||||||||||||||
| Due after one year through five years | |||||||||||||||||||||||
| Due after five years through ten years | |||||||||||||||||||||||
| Due after ten years | |||||||||||||||||||||||
| Total | $ | $ | $ | $ | |||||||||||||||||||
Actual maturities may differ from contractual maturities because certain securities may be called or prepaid. Securities not due at a single date are allocated based on weighted average life.
Mortgage Loans
The following table presents the amortized cost basis of mortgage loans for each credit quality indicator by year of origination. The primary credit quality indicators utilized are debt service coverage ratios (DSCR) and loan-to-value ratios (LTV).
| September 30, 2026 | Mortgage Loans Amortized Cost Basis by Origination Year (1) | ||||||||||||||||||||||||||||||||||||||||
| (In millions) | 2026 | 2025 | 2024 | 2023 | 2022 | Prior | Total | ||||||||||||||||||||||||||||||||||
| DSCR ≥1.6x | |||||||||||||||||||||||||||||||||||||||||
| LTV less than 55% | $ | $ | $ | $ | $ | $ | $ | ||||||||||||||||||||||||||||||||||
| LTV 55% to 65% | |||||||||||||||||||||||||||||||||||||||||
| LTV greater than 65% | |||||||||||||||||||||||||||||||||||||||||
| DSCR 1.2x - 1.6x | |||||||||||||||||||||||||||||||||||||||||
| LTV less than 55% | |||||||||||||||||||||||||||||||||||||||||
| LTV 55% to 65% | |||||||||||||||||||||||||||||||||||||||||
| LTV greater than 65% | |||||||||||||||||||||||||||||||||||||||||
| DSCR ≤1.2x | |||||||||||||||||||||||||||||||||||||||||
| LTV less than 55% | |||||||||||||||||||||||||||||||||||||||||
| LTV 55% to 65% | |||||||||||||||||||||||||||||||||||||||||
| LTV greater than 65% | |||||||||||||||||||||||||||||||||||||||||
| Total | $ | $ | $ | $ | $ | $ | $ | ||||||||||||||||||||||||||||||||||
(1) The values in the table above reflect DSCR on a standardized amortization period and LTV based on the most recent appraised values trended forward using changes in a commercial real estate price index.
As of September 30, 2026, accrued interest receivable on mortgage loans totaled $5 million and is excluded from the amortized cost basis disclosed in the table above and the estimate of expected credit losses.
Investment Commitments
As part of its overall investment strategy, the Company invests in various assets which require future purchase, sale or funding commitments. These investments are recorded once funded, and the related commitments may include future capital calls from various third-party limited partnerships, signed and accepted mortgage loan applications, and obligations related to private placement securities. As of September 30, 2026, the Company had commitments to purchase or fund approximately $2,085 million and sell approximately $50 million under the terms of these investments.
16
Table of Contents
Note D. Fair Value
Fair value is the price that would be received upon sale of an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. The following fair value hierarchy is used in selecting inputs, with the highest priority given to Level 1, as these are the most transparent or reliable.
Level 1 - Quoted prices for identical instruments in active markets.
Level 2 - Quoted prices for similar instruments in active markets; quoted prices for identical or similar instruments in markets that are not active; and model-derived valuations in which all significant inputs are observable in active markets.
Level 3 - Valuations derived from valuation techniques in which one or more significant inputs are not observable.
Prices may fall within Level 1, 2 or 3 depending upon the methodology and inputs used to estimate fair value for each specific security. In general, the Company seeks to price securities using third-party pricing services. Securities not priced by pricing services are submitted to independent brokers for valuation and, if those are not available, internally developed pricing models are used to value assets using a methodology and inputs the Company believes market participants would use to value the assets. Prices obtained from third-party pricing services or brokers are not adjusted by the Company.
The Company performs control procedures over information obtained from pricing services and brokers to ensure prices received represent a reasonable estimate of fair value and to confirm representations regarding whether inputs are observable or unobservable. Procedures may include i) the review of pricing service methodologies or broker pricing qualifications, ii) back-testing, where past fair value estimates are compared to actual transactions executed in the market on similar dates, iii) exception reporting, where period-over-period changes in price are reviewed and challenged with the pricing service or broker based on exception criteria, and iv) deep dives, where the Company performs an independent analysis of the inputs and assumptions used to price individual securities.
17
Table of Contents
Assets and Liabilities Measured at Fair Value
Assets measured at fair value on a recurring basis are presented in the following tables. Corporate bonds and other includes obligations of the United States of America (U.S.) Treasury, government-sponsored enterprises, foreign governments and redeemable preferred stock. The Company had no liabilities measured at fair value as of September 30, 2026 or December 31, 2025.
| September 30, 2026 | Total | ||||||||||||||||||||||
| (In millions) | Level 1 | Level 2 | Level 3 | ||||||||||||||||||||
| Assets | |||||||||||||||||||||||
| Fixed maturity securities: | |||||||||||||||||||||||
| Corporate bonds and other | $ | $ | $ | $ | |||||||||||||||||||
| States, municipalities and political subdivisions | |||||||||||||||||||||||
| Asset-backed | |||||||||||||||||||||||
| Total fixed maturity securities | |||||||||||||||||||||||
| Equity securities: | |||||||||||||||||||||||
| Common stock | |||||||||||||||||||||||
| Non-redeemable preferred stock | |||||||||||||||||||||||
| Total equity securities | |||||||||||||||||||||||
| Short-term and other | |||||||||||||||||||||||
| Total assets | $ | $ | $ | $ | |||||||||||||||||||
| December 31, 2025 | Total | ||||||||||||||||||||||
| (In millions) | Level 1 | Level 2 | Level 3 | ||||||||||||||||||||
| Assets | |||||||||||||||||||||||
| Fixed maturity securities: | |||||||||||||||||||||||
| Corporate bonds and other | $ | $ | $ | $ | |||||||||||||||||||
| States, municipalities and political subdivisions | |||||||||||||||||||||||
| Asset-backed | |||||||||||||||||||||||
| Total fixed maturity securities | |||||||||||||||||||||||
| Equity securities: | |||||||||||||||||||||||
| Common stock | |||||||||||||||||||||||
| Non-redeemable preferred stock | |||||||||||||||||||||||
| Total equity securities | |||||||||||||||||||||||
| Short-term and other | |||||||||||||||||||||||
| Total assets | $ | $ | $ | $ | |||||||||||||||||||
18
Table of Contents
The tables below present a reconciliation for all assets and liabilities measured at fair value on a recurring basis using significant unobservable inputs (Level 3).
Level 3 (In millions) | Corporate bonds and other | States, municipalities and political subdivisions | Asset-backed | Equity securities | Total | ||||||||||||||||||||||||||||||
Balance as of July 1, 2026 | $ | $ | $ | $ | $ | ||||||||||||||||||||||||||||||
| Total realized and unrealized investment gains (losses): | |||||||||||||||||||||||||||||||||||
| Reported in Net investment gains (losses) | ( | ( | ( | ||||||||||||||||||||||||||||||||
| Reported in Net investment income | |||||||||||||||||||||||||||||||||||
| Reported in Other comprehensive income (loss) | ( | ( | ( | ( | |||||||||||||||||||||||||||||||
| Total realized and unrealized investment gains (losses) | ( | ( | ( | ( | |||||||||||||||||||||||||||||||
| Purchases | |||||||||||||||||||||||||||||||||||
| Sales | |||||||||||||||||||||||||||||||||||
| Settlements | ( | ( | ( | ( | |||||||||||||||||||||||||||||||
| Transfers into Level 3 | |||||||||||||||||||||||||||||||||||
| Transfers out of Level 3 | ( | ( | ( | ||||||||||||||||||||||||||||||||
Balance as of September 30, 2026 | $ | $ | $ | $ | $ | ||||||||||||||||||||||||||||||
Unrealized gains (losses) on Level 3 assets and liabilities held as of September 30, 2026 recognized in Net income (loss) in the period | $ | $ | $ | $ | $ | ||||||||||||||||||||||||||||||
Unrealized gains (losses) on Level 3 assets and liabilities held as of September 30, 2026 recognized in Other comprehensive income (loss) in the period | ( | ( | ( | ( | |||||||||||||||||||||||||||||||
Level 3 (In millions) | Corporate bonds and other | States, municipalities and political subdivisions | Asset-backed | Equity securities | Total | ||||||||||||||||||||||||||||||
Balance as of July 1, 2025 | $ | $ | $ | $ | $ | ||||||||||||||||||||||||||||||
| Total realized and unrealized investment gains (losses): | |||||||||||||||||||||||||||||||||||
| Reported in Net investment gains (losses) | |||||||||||||||||||||||||||||||||||
| Reported in Net investment income | |||||||||||||||||||||||||||||||||||
| Reported in Other comprehensive income (loss) | |||||||||||||||||||||||||||||||||||
| Total realized and unrealized investment gains (losses) | |||||||||||||||||||||||||||||||||||
| Purchases | |||||||||||||||||||||||||||||||||||
| Sales | |||||||||||||||||||||||||||||||||||
| Settlements | ( | ( | ( | ||||||||||||||||||||||||||||||||
| Transfers into Level 3 | |||||||||||||||||||||||||||||||||||
| Transfers out of Level 3 | |||||||||||||||||||||||||||||||||||
Balance as of September 30, 2025 | $ | $ | $ | $ | $ | ||||||||||||||||||||||||||||||
Unrealized gains (losses) on Level 3 assets and liabilities held as of September 30, 2025 recognized in Net income (loss) in the period | $ | $ | $ | $ | $ | ||||||||||||||||||||||||||||||
Unrealized gains (losses) on Level 3 assets and liabilities held as of September 30, 2025 recognized in Other comprehensive income (loss) in the period | |||||||||||||||||||||||||||||||||||
19
Table of Contents
Level 3 (In millions) | Corporate bonds and other | States, municipalities and political subdivisions | Asset-backed | Equity securities | Total | ||||||||||||||||||||||||||||||
Balance as of January 1, 2026 | $ | $ | $ | $ | $ | ||||||||||||||||||||||||||||||
| Total realized and unrealized investment gains (losses): | |||||||||||||||||||||||||||||||||||
| Reported in Net investment gains (losses) | ( | ( | ( | ||||||||||||||||||||||||||||||||
| Reported in Net investment income | |||||||||||||||||||||||||||||||||||
| Reported in Other comprehensive income (loss) | ( | ( | ( | ( | |||||||||||||||||||||||||||||||
| Total realized and unrealized investment gains (losses) | ( | ( | ( | ( | |||||||||||||||||||||||||||||||
| Purchases | |||||||||||||||||||||||||||||||||||
| Sales | ( | ( | |||||||||||||||||||||||||||||||||
| Settlements | ( | ( | ( | ( | |||||||||||||||||||||||||||||||
| Transfers into Level 3 | |||||||||||||||||||||||||||||||||||
| Transfers out of Level 3 | ( | ( | ( | ||||||||||||||||||||||||||||||||
Balance as of September 30, 2026 | $ | $ | $ | $ | $ | ||||||||||||||||||||||||||||||
Unrealized gains (losses) on Level 3 assets and liabilities held as of September 30, 2026 recognized in Net income (loss) in the period | $ | $ | $ | $ | $ | ||||||||||||||||||||||||||||||
Unrealized gains (losses) on Level 3 assets and liabilities held as of September 30, 2026 recognized in Other comprehensive income (loss) in the period | ( | ( | ( | ( | |||||||||||||||||||||||||||||||
Level 3 (In millions) | Corporate bonds and other | States, municipalities and political subdivisions | Asset-backed | Equity securities | Total | ||||||||||||||||||||||||||||||
Balance as of January 1, 2025 | $ | $ | $ | $ | $ | ||||||||||||||||||||||||||||||
| Total realized and unrealized investment gains (losses): | |||||||||||||||||||||||||||||||||||
| Reported in Net investment gains (losses) | ( | ||||||||||||||||||||||||||||||||||
| Reported in Net investment income | ( | ||||||||||||||||||||||||||||||||||
| Reported in Other comprehensive income (loss) | |||||||||||||||||||||||||||||||||||
| Total realized and unrealized investment gains (losses) | |||||||||||||||||||||||||||||||||||
| Purchases | |||||||||||||||||||||||||||||||||||
| Sales | ( | ( | |||||||||||||||||||||||||||||||||
| Settlements | ( | ( | ( | ( | |||||||||||||||||||||||||||||||
| Transfers into Level 3 | |||||||||||||||||||||||||||||||||||
| Transfers out of Level 3 | |||||||||||||||||||||||||||||||||||
Balance as of September 30, 2025 | $ | $ | $ | $ | $ | ||||||||||||||||||||||||||||||
Unrealized gains (losses) on Level 3 assets and liabilities held as of September 30, 2025 recognized in Net income (loss) in the period | $ | $ | $ | $ | ( | $ | ( | ||||||||||||||||||||||||||||
Unrealized gains (losses) on Level 3 assets and liabilities held as of September 30, 2025 recognized in Other comprehensive income (loss) in the period | |||||||||||||||||||||||||||||||||||
Securities may be transferred in or out of levels within the fair value hierarchy based on the availability of observable market information and quoted prices used to determine the fair value of the security. The availability of observable market information and quoted prices varies based on market conditions and trading volume.
20
Table of Contents
Valuation Methodologies and Inputs
The following section describes the valuation methodologies and relevant inputs used to measure different financial instruments at fair value, including an indication of the level in the fair value hierarchy in which the instruments are generally classified.
Fixed Maturity Securities
Level 1 securities include highly liquid government securities and exchange traded bonds, valued using quoted market prices. Level 2 securities include most other fixed maturity securities as the significant inputs are observable in the marketplace. All classes of Level 2 fixed maturity securities are valued using a methodology based on information generated by market transactions involving identical or comparable assets, a discounted cash flow methodology, or a combination of both when necessary. Common inputs for all classes of fixed maturity securities include prices from recently executed transactions of similar securities, marketplace quotes, benchmark yields, spreads off benchmark yields, interest rates and U.S. Treasury or swap curves. Specifically for asset-backed securities, key inputs include prepayment and default projections based on past performance of the underlying collateral and current market data. Fixed maturity securities are primarily assigned to Level 3 in cases where broker/dealer quotes are significant inputs to the valuation and there is a lack of transparency as to whether these quotes are based on information that is observable in the marketplace. Level 3 securities also include private placement debt securities whose fair value is determined using internal models with some inputs that are not market observable.
Equity Securities
Level 1 equity securities include publicly traded securities valued using quoted market prices. Level 2 securities are primarily valued using pricing for similar securities, recently executed transactions and other pricing models utilizing market observable inputs. Level 3 securities are primarily priced using broker/dealer quotes and internal models with some inputs that are not market observable.
Short-Term and Other Invested Assets
Securities that are actively traded or have quoted prices are classified as Level 1. These securities include money market funds and treasury bills. Level 2 primarily includes non-U.S. government securities for which all inputs are market observable. Fixed maturity securities purchased within one year of maturity are classified consistent with fixed maturity securities discussed above. Short-term investments as presented in the tables above differ from the amounts presented on the Condensed Consolidated Balance Sheets because certain short-term investments, such as time deposits, are not measured at fair value.
As of September 30, 2026 and December 31, 2025, there were $106 million and $99 million of overseas and other regulatory deposits within Other invested assets, which, subject to regulatory minimum balance requirements, can be redeemed at net asset value in 90 days or less. These deposits are excluded from the fair value hierarchy because their fair value is recorded using the net asset value per share (or equivalent) practical expedient.
21
Table of Contents
Significant Unobservable Inputs
The following tables present quantitative information about the significant unobservable inputs utilized by the Company in the fair value measurements of Level 3 assets. Valuations for assets and liabilities not presented in the tables below are primarily based on broker/dealer quotes for which there is a lack of transparency as to inputs used to develop the valuations. The quantitative detail of these unobservable inputs is neither provided nor reasonably available to the Company. The weighted average rate is calculated based on fair value.
| September 30, 2026 | Estimated Fair Value (In millions) | Valuation Technique(s) | Unobservable Input(s) | Range (Weighted Average) | |||||||||||||||||||
| Fixed maturity securities | $ | Discounted cash flow | Credit spread | ||||||||||||||||||||
| December 31, 2025 | Estimated Fair Value (In millions) | Valuation Technique(s) | Unobservable Input(s) | Range (Weighted Average) | |||||||||||||||||||
| Fixed maturity securities | $ | Discounted cash flow | Credit spread | ||||||||||||||||||||
For fixed maturity securities, an increase to the credit spread assumptions would result in a lower fair value measurement.
Financial Assets and Liabilities Not Measured at Fair Value
The carrying amount and estimated fair value of the Company's financial assets and liabilities which are not measured at fair value on the Condensed Consolidated Balance Sheets are presented in the following tables.
| September 30, 2026 | Carrying Amount | Estimated Fair Value | |||||||||||||||||||||||||||
| (In millions) | Level 1 | Level 2 | Level 3 | Total | |||||||||||||||||||||||||
| Assets | |||||||||||||||||||||||||||||
| Mortgage loans | $ | $ | $ | $ | $ | ||||||||||||||||||||||||
| Liabilities | |||||||||||||||||||||||||||||
| Short-term debt | $ | $ | $ | $ | $ | ||||||||||||||||||||||||
| Long-term debt | |||||||||||||||||||||||||||||
| December 31, 2025 | Carrying Amount | Estimated Fair Value | |||||||||||||||||||||||||||
| (In millions) | Level 1 | Level 2 | Level 3 | Total | |||||||||||||||||||||||||
| Assets | |||||||||||||||||||||||||||||
| Mortgage loans | $ | $ | $ | $ | $ | ||||||||||||||||||||||||
| Liabilities | |||||||||||||||||||||||||||||
| Short-term debt | $ | $ | $ | $ | $ | ||||||||||||||||||||||||
| Long-term debt | |||||||||||||||||||||||||||||
The carrying amounts reported on the Condensed Consolidated Balance Sheets for Cash, Short-term investments not carried at fair value, Accrued investment income and certain Other assets and Other liabilities approximate fair value due to the short-term nature of these items. These assets and liabilities are not listed in the tables above.
22
Table of Contents
Note E. Claim and Claim Adjustment Expense Reserves
Claim and claim adjustment expense reserves represent the estimated amounts necessary to resolve all outstanding claims, including incurred but not reported (IBNR) claims as of the reporting date. The Company's reserve projections are based primarily on detailed analysis of the facts in each case, the Company's experience with similar cases and various historical development patterns. Consideration is given to historical patterns such as claim reserving trends and settlement practices, loss payments, pending levels of unpaid claims and product mix, economic, medical and social inflation, and public attitudes. All of these factors can affect the estimation of claim and claim adjustment expense reserves.
Establishing claim and claim adjustment expense reserves, including claim and claim adjustment expense reserves for catastrophic events that have occurred, is an estimation process. Many factors can ultimately affect the final settlement of a claim and, therefore, the necessary reserve. Changes in the law, results of litigation, medical costs, the cost of repair materials and labor rates can affect ultimate claim costs. In addition, time can be a critical part of reserving determinations since the longer the span between the incidence of a loss and the payment or settlement of the claim, the more variable the ultimate settlement amount can be. Accordingly, short-tail claims, such as property damage claims, tend to be more reasonably estimable than long-tail claims, such as workers' compensation, general liability and professional liability claims. Claim and claim adjustment expense reserves are also maintained for the Company's structured settlement obligations. In developing the claim and claim adjustment expense reserve estimates for structured settlement obligations, the Company's actuaries review mortality experience on an annual basis. Adjustments to prior year reserve estimates, if necessary, are reflected in the results of operations in the period that the need for such adjustments is determined. There can be no assurance that the Company's ultimate cost for insurance losses will not exceed current estimates.
Catastrophes are an inherent risk of the property and casualty insurance business and have contributed to material period-to-period fluctuations in our results of operations and/or equity. Catastrophe-related reinstatement premiums represent additional consideration paid under certain reinsurance agreements to reinstate coverage limits that have been exhausted as a result of losses. The Company reported catastrophe losses, net of reinsurance, of $78 million and $226 million for the three and nine months ended September 30, 2026 and $41 million and $200 million for the three and nine months ended September 30, 2025 driven by severe weather related events. The Company also reported catastrophe-related reinsurance reinstatement premiums of $9 million for the nine months ended September 30, 2026. There were no
23
Table of Contents
Liability for Unpaid Claim and Claim Adjustment Expenses
The following table presents a reconciliation between beginning and ending claim and claim adjustment expense reserves.
For the nine months ended September 30 | |||||||||||
| (In millions) | 2026 | 2025 | |||||||||
| Reserves, beginning of year: | |||||||||||
| Gross | $ | $ | |||||||||
| Ceded | |||||||||||
| Net reserves, beginning of year | |||||||||||
| Net incurred claim and claim adjustment expenses: | |||||||||||
| Provision for insured events of current year | |||||||||||
| Increase (decrease) in provision for insured events of prior years | |||||||||||
| Amortization of discount | |||||||||||
Total net incurred (1) | |||||||||||
| Net payments attributable to: | |||||||||||
| Current year events | ( | ( | |||||||||
| Prior year events | ( | ( | |||||||||
| Total net payments | ( | ( | |||||||||
| Foreign currency translation adjustment and other | ( | ||||||||||
| Net reserves, end of period | |||||||||||
| Ceded reserves, end of period | |||||||||||
| Gross reserves, end of period | $ | $ | |||||||||
(1) Total net incurred does not agree to Insurance claims and policyholders' benefits as reflected on the Condensed Consolidated Statements of Operations due to amounts related to retroactive reinsurance deferred gain accounting, uncollectible reinsurance and benefit expenses related to future policy benefits and policyholders' dividends, which are not reflected in the table above.
Net Prior Year Development
Changes in estimates of claim and claim adjustment expense reserves, net of reinsurance, for prior years are defined as net prior year loss reserve development (development). These changes can be favorable or unfavorable. The following table presents development recorded for the Specialty, Commercial, International and Corporate & Other segments.
| Periods ended September 30 | Three Months | Nine Months | |||||||||||||||||||||
| (In millions) | 2026 | 2025 | 2026 | 2025 | |||||||||||||||||||
| Pretax (favorable) unfavorable development: | |||||||||||||||||||||||
| Specialty | $ | $ | $ | $ | |||||||||||||||||||
| Commercial | ( | ||||||||||||||||||||||
| International | ( | ( | |||||||||||||||||||||
| Corporate & Other | |||||||||||||||||||||||
| Total pretax (favorable) unfavorable development | $ | ( | $ | ( | $ | $ | |||||||||||||||||
Unfavorable development of $97 million and $134 million was recorded within the Corporate & Other segment for the nine months ended September 30, 2026 and 2025, largely associated with legacy mass tort abuse claim activity and the ongoing effects of social inflation. Unfavorable development for the nine months ended September 30, 2025 also included an agreement with the Diocese of Rochester.
24
Table of Contents
Specialty
The following table presents further detail of the development recorded for the Specialty segment.
| Periods ended September 30 | Three Months | Nine Months | |||||||||||||||||||||
| (In millions) | 2026 | 2025 | 2026 | 2025 | |||||||||||||||||||
| Pretax (favorable) unfavorable development: | |||||||||||||||||||||||
| Medical Professional Liability | $ | $ | $ | $ | |||||||||||||||||||
| Other Professional Liability and Management Liability | |||||||||||||||||||||||
| Surety | ( | ( | ( | ( | |||||||||||||||||||
| Warranty | ( | ( | |||||||||||||||||||||
| Other | |||||||||||||||||||||||
| Total pretax (favorable) unfavorable development | $ | $ | $ | $ | |||||||||||||||||||
Three Months
2026
Unfavorable development in other professional liability and management liability was primarily due to higher than expected claim severity and frequency across multiple accident years.
Favorable development in surety was primarily due to lower than expected frequency and lack of systemic activity in multiple accident years.
2025
Unfavorable development in other professional liability and management liability was primarily due to higher than expected claim severity and frequency in the Company's professional errors and omissions (E&O) business.
Favorable development in surety was primarily due to lower than expected frequency and lack of systemic activity in multiple accident years.
Nine Months
2026
Unfavorable development in other professional liability and management liability was primarily due to higher than expected claim severity and frequency across multiple accident years.
Favorable development in surety was primarily due to lower than expected frequency and lack of systemic activity in multiple accident years.
2025
Unfavorable development in other professional liability and management liability was primarily due to higher than expected claim severity and frequency in the Company's professional E&O business.
Favorable development in surety was primarily due to lower than expected frequency and lack of systemic activity in multiple accident years.
Unfavorable development in warranty was primarily due to higher than expected frequency and severity in the most recent accident year for auto warranty.
25
Table of Contents
Commercial
The following table presents further detail of the development recorded for the Commercial segment.
| Periods ended September 30 | Three Months | Nine Months | |||||||||||||||||||||
| (In millions) | 2026 | 2025 | 2026 | 2025 | |||||||||||||||||||
| Pretax (favorable) unfavorable development: | |||||||||||||||||||||||
| Commercial Auto | $ | $ | $ | $ | |||||||||||||||||||
| General Liability | |||||||||||||||||||||||
| Workers' Compensation | ( | ( | ( | ( | |||||||||||||||||||
| Property and Other | ( | ( | |||||||||||||||||||||
| Total pretax (favorable) unfavorable development | $ | $ | ( | $ | $ | ||||||||||||||||||
Three Months
2026
Unfavorable development in general liability was due to higher than expected claim severity and frequency in recent prior accident years.
Favorable development in workers’ compensation was due to favorable medical trends driving lower than expected severity in older accident years.
Favorable development in property and other was due to favorable emergence in multiple accident years.
Nine Months
2026
Unfavorable development in general liability was due to higher than expected claim severity and frequency in recent prior accident years.
Favorable development in workers’ compensation was due to favorable medical trends driving lower than expected severity in multiple accident years.
Favorable development in property and other was due to favorable emergence in multiple accident years.
2025
Unfavorable development in commercial auto was due to higher than expected claim severity largely in the Company’s construction business in the most recent accident year.
Unfavorable development in general liability was due to higher than expected claim severity in multiple accident years going back to 2016.
Favorable development in workers’ compensation was due to favorable medical trends driving lower than expected severity in multiple accident years.
26
Table of Contents
International
The following table presents further detail of the development recorded for the International segment.
| Periods ended September 30 | Three Months | Nine Months | |||||||||||||||||||||
| (In millions) | 2026 | 2025 | 2026 | 2025 | |||||||||||||||||||
| Pretax (favorable) unfavorable development: | |||||||||||||||||||||||
| Commercial | $ | ( | $ | ( | $ | ( | $ | ( | |||||||||||||||
| Specialty | ( | ||||||||||||||||||||||
| Other | ( | ||||||||||||||||||||||
| Total pretax (favorable) unfavorable development | $ | ( | $ | $ | ( | $ | |||||||||||||||||
Three Months
2026
Favorable development in commercial was due to better than expected loss experience in the Company's property business.
Favorable development in specialty was due to better than expected loss experience in the Company's professional liability and management liability businesses.
Nine Months
2026
Favorable development in commercial was due to better than expected loss experience in the Company's energy, middle market, property and marine businesses.
27
Table of Contents
Asbestos & Environmental Pollution (A&EP) Reserves
In 2010, Continental Casualty Company (CCC) together with several of the Company’s insurance subsidiaries completed a transaction with National Indemnity Company (NICO), a subsidiary of Berkshire Hathaway Inc., under which substantially all of the Company’s legacy A&EP liabilities were ceded to NICO through a Loss Portfolio Transfer (LPT). At the effective date of the transaction, the Company ceded approximately $1.6 billion of net A&EP claim and allocated claim adjustment expense reserves to NICO under a retroactive reinsurance agreement with an aggregate limit of $4 billion. The $1.6 billion of claim and allocated claim adjustment expense reserves ceded to NICO was net of $1.2 billion of ceded claim and allocated claim adjustment expense reserves under existing third-party reinsurance contracts. The NICO LPT aggregate reinsurance limit also covers credit risk on the existing third-party reinsurance related to these liabilities. The Company paid NICO a reinsurance premium of $2 billion and transferred to NICO billed third-party reinsurance receivables related to A&EP claims with a net book value of $215 million, resulting in total consideration of $2.2 billion.
In years subsequent to the effective date of the LPT, the Company recognized adverse prior year development on its A&EP reserves resulting in additional amounts ceded under the LPT. As a result, the cumulative amounts ceded under the LPT have exceeded the $2.2 billion consideration paid, resulting in the NICO LPT moving into a gain position, requiring retroactive reinsurance accounting. Under retroactive reinsurance accounting, this gain is deferred and only recognized in earnings in proportion to actual paid recoveries under the LPT. Over the life of the contract, there is no economic impact as long as any additional losses incurred are within the limit of the LPT. In a period in which the Company recognizes a change in the estimate of A&EP reserves that increases or decreases the amounts ceded under the LPT, the proportion of actual paid recoveries to total ceded losses is affected and the change in the deferred gain is recognized in earnings as if the revised estimate of ceded losses was available at the effective date of the LPT. The effect of the deferred retroactive reinsurance benefit is recorded in Insurance claims and policyholders' benefits in the Condensed Consolidated Statements of Operations.
The impact of the LPT on the Condensed Consolidated Statements of Operations was the recognition of a retroactive reinsurance benefit of $11 million and $14 million for the three months ended September 30, 2026 and 2025 and $57 million and $39 million for the nine months ended September 30, 2026 and 2025. As of September 30, 2026 and December 31, 2025, the cumulative amounts ceded under the LPT were $3.9 billion. The unrecognized deferred retroactive reinsurance benefit was $413 million and $470 million as of September 30, 2026 and December 31, 2025 and is included within Other liabilities on the Condensed Consolidated Balance Sheets.
NICO established a collateral trust account as security for its obligations to the Company. The fair value of the collateral trust account was $1.9 billion as of September 30, 2026. In addition, Berkshire Hathaway Inc. guaranteed the payment obligations of NICO up to the aggregate reinsurance limit as well as certain of NICO’s performance obligations under the trust agreement. NICO is responsible for claims handling and billing and collection from third-party reinsurers related to the majority of the Company’s A&EP claims.
Credit Risk for Ceded Reserves
The majority of the Company’s outstanding voluntary reinsurance receivables are due from reinsurers with financial strength ratings of A- or higher. Receivables due from reinsurers with lower financial strength ratings are primarily due from captive reinsurers and are backed by collateral arrangements.
28
Table of Contents
Note F. Future Policy Benefits Reserves
Future policy benefits reserves are associated with the Company's run-off long-term care business, which is included in the Life & Group segment, and relate to policyholders that are currently receiving benefits, including claims that have been incurred but are not yet reported, as well as policyholders that are not yet receiving benefits. Future policy benefits reserves are comprised of the liability for future policyholder benefits (LFPB) which is reflected as Insurance reserves: Future policy benefits on the Condensed Consolidated Balance Sheets.
The determination of Future policy benefits reserves requires management to make estimates and assumptions about expected policyholder experience over the remaining life of the policy. Since policies may be in force for several decades, these assumptions are subject to significant estimation risk. As a result of this variability, the Company’s future policy benefits reserves may be subject to material increases if actual experience develops adversely to the Company’s expectations.
Annually in the third quarter, actuarial analysis is performed on policyholder morbidity, persistency, premium rate actions and expense experience. This analysis, combined with judgment, informs the setting of updated cash flow assumptions used to estimate the LFPB. Actuarial analysis includes predictive modeling, actual to expected experience comparisons and trend analysis. Applicable industry research is also considered.
The cash flow assumption updates for the third quarter of 2026 resulted in a $173 million pretax increase in the LFPB. Included in the assumption updates were unfavorable cost of care inflation and morbidity impacts, partially offset by favorable premium rate actions.
The cash flow assumption updates for the third quarter of 2025 resulted in a $7 million pretax increase in the LFPB. Included in the assumption updates were unfavorable incidence, claim closure and cost of care inflation impacts, offset by favorable premium rate actions.
See Note A to the Consolidated Financial Statements within CNAF's Annual Report on Form 10-K for the year ended December 31, 2025 for further information on the long-term care reserving process.
29
Table of Contents
The following table summarizes balances and changes in the LFPB.
(In millions) | 2026 | 2025 | ||||||||||||
| Present value of future net premiums | ||||||||||||||
| Balance, January 1 | $ | $ | ||||||||||||
| Effect of changes in discount rate | ( | ( | ||||||||||||
| Balance, January 1, at original locked in discount rate | ||||||||||||||
Effect of changes in cash flow assumptions (1) | ||||||||||||||
Effect of actual variances from expected experience (1) | ( | ( | ||||||||||||
| Adjusted balance, January 1 | ||||||||||||||
| Interest accrual | ||||||||||||||
| Net premiums: earned during period | ( | ( | ||||||||||||
| Balance, end of period at original locked in discount rate | ||||||||||||||
| Effect of changes in discount rate | ( | |||||||||||||
Balance, September 30 | $ | $ | ||||||||||||
| Present value of future benefits & expenses | ||||||||||||||
| Balance, January 1 | $ | $ | ||||||||||||
| Effect of changes in discount rate | ||||||||||||||
| Balance, January 1, at original locked in discount rate | ||||||||||||||
Effect of changes in cash flow assumptions (1) | ||||||||||||||
Effect of actual variances from expected experience (1) | ||||||||||||||
| Adjusted balance, January 1 | ||||||||||||||
| Interest accrual | ||||||||||||||
| Benefit & expense payments | ( | ( | ||||||||||||
| Balance, end of period at original locked in discount rate | ||||||||||||||
| Effect of changes in discount rate | ( | ( | ||||||||||||
Balance, September 30 | $ | $ | ||||||||||||
| Net LFPB | $ | $ | ||||||||||||
(1) As of September 30, 2026 and 2025 the re-measurement gain (loss) of $(266 ) million and $(59 ) million presented parenthetically on the Condensed Consolidated Statement of Operations is comprised of the effect of changes in cash flow assumptions and the effect of actual variances from expected experience.
30
Table of Contents
The following table presents earned premiums and interest accretion associated with the Company’s long-term care business recognized on the Condensed Consolidated Statement of Operations.
| Periods ended September 30 | Three Months | Nine Months | |||||||||||||||||||||
(In millions) | 2026 | 2025 | 2026 | 2025 | |||||||||||||||||||
| Earned premiums | $ | $ | $ | $ | |||||||||||||||||||
| Interest accretion | |||||||||||||||||||||||
The following table presents undiscounted expected future benefit and expense payments, and undiscounted expected future gross premiums.
As of September 30 | |||||||||||
(In millions) | 2026 | 2025 | |||||||||
| Expected future benefit and expense payments | $ | $ | |||||||||
| Expected future gross premiums | |||||||||||
Discounted expected future gross premiums at the upper-medium grade fixed income instrument yield discount rate were $3,136 million and $3,580 million as of September 30, 2026 and 2025.
The weighted average effective duration of the LFPB calculated using the original locked in discount rate was 11
The weighted average interest rates in the table below are calculated based on the rate used to discount all future cash flows.
As of September 30 | As of December 31 | ||||||||||||||||
| 2026 | 2025 | 2025 | |||||||||||||||
| Original locked in discount rate | % | % | % | ||||||||||||||
| Upper-medium grade fixed income instrument discount rate | |||||||||||||||||
For the three and nine months ended September 30, 2026, immediate charges to net income resulting from adverse development in certain cohorts where the Net Premium Ratio (NPR) exceeded 100% were $218 million and $267 million. For the three and nine months ended September 30, 2025, immediate charges to net income resulting from adverse development in certain cohorts where the NPR exceeded 100% were $65 million and $93 million.
For the three and nine months ended September 30, 2026, favorable reversals through net income of loss recognized in prior periods for cohorts with NPR's exceeding 100% were less than $1 million and $13 million. For the three and nine months ended September 30, 2025, favorable reversals through net income of loss recognized in prior periods for cohorts with NPR's exceeding 100% were $43 million and $54 million.
31
Table of Contents
Note G. Legal Proceedings, Contingencies and Guarantees
The Company is a party to various claims and litigation incidental to its business, which, based on the facts and circumstances currently known, are not material to the Company's results of operations or financial position.
Guarantees
The Company has provided guarantees, if the primary obligor fails to perform, to holders of structured settlement annuities issued by a previously owned subsidiary. As of September 30, 2026, the potential amount of future payments the Company could be required to pay under these guarantees was approximately $1.8 billion, which will be paid over the lifetime of the annuitants. The Company does not believe any payment is likely under these guarantees, as the Company is the beneficiary of a trust that must be maintained at a level that approximates the discounted reserves for these annuities.
32
Table of Contents
Note H. Benefit Plans
The components of net periodic pension cost (benefit) are presented in the following table.
| Periods ended September 30 | Three Months | Nine Months | |||||||||||||||||||||
| (In millions) | 2026 | 2025 | 2026 | 2025 | |||||||||||||||||||
| Net periodic pension cost (benefit) | |||||||||||||||||||||||
| Interest cost on projected benefit obligation | $ | $ | $ | $ | |||||||||||||||||||
| Expected return on plan assets | ( | ( | ( | ( | |||||||||||||||||||
| Amortization of net actuarial loss (gain) | |||||||||||||||||||||||
| Total net periodic pension cost (benefit) | $ | ( | $ | ( | $ | ( | $ | ( | |||||||||||||||
The following table indicates the line items in which the non-service cost (benefit) is presented in the Condensed Consolidated Statements of Operations.
| Periods ended September 30 | Three Months | Nine Months | |||||||||||||||||||||
| (In millions) | 2026 | 2025 | 2026 | 2025 | |||||||||||||||||||
| Non-service cost (benefit): | |||||||||||||||||||||||
| Insurance claims and policyholders' benefits | $ | ( | $ | ( | $ | ( | $ | ( | |||||||||||||||
| Other operating expenses | ( | ( | ( | ( | |||||||||||||||||||
| Total net periodic pension cost (benefit) | $ | ( | $ | ( | $ | ( | $ | ( | |||||||||||||||
CNA sponsors a noncontributory defined benefit pension plan, the CNA Retirement Plan (the Plan), covering certain eligible employees. The plan has been closed to new entrants since 2000. In the first quarter of 2026, a subsidiary of CNAF, as sponsor of the Plan, approved the decision to pursue termination of the Plan, effective June 30, 2026. The Plan will continue to be reflected in CNA's consolidated financial statements until the termination process, including the settlement or transfer of remaining benefit obligations, has been completed, which the Company currently anticipates will be in 2028.
33
Table of Contents
Note I. Stockholders' Equity
Common Stock Repurchases
The Company repurchased 755,000 and 700,000 shares of CNAF common stock at an aggregate cost of $36 million and $34 million during the nine months ended September 30, 2026 and 2025.
Stock-Based Compensation
The Company issued 690,436 and 521,903 shares of CNAF common stock to settle employee stock-based compensation awards under the CNAF Incentive Compensation Plan during the nine months ended September 30, 2026 and 2025.
Accumulated Other Comprehensive Income (Loss)
The tables below display the changes in Accumulated other comprehensive income (loss) by component.
| (In millions) | Net unrealized gains (losses) on investments with an allowance for credit losses | Net unrealized gains (losses) on other investments | Pension and postretirement benefits | Cumulative impact of changes in discount rates used to measure long duration contracts | Cumulative foreign currency translation adjustment | Total | |||||||||||||||||||||||||||||
Balance as of July 1, 2026 | $ | ( | $ | ( | $ | ( | $ | $ | ( | $ | ( | ||||||||||||||||||||||||
| Other comprehensive income (loss) before reclassifications | ( | ( | ( | ( | |||||||||||||||||||||||||||||||
Amounts reclassified from accumulated other comprehensive income (loss) net of tax (expense) benefit of $ | ( | ||||||||||||||||||||||||||||||||||
Other comprehensive income (loss) net of tax (expense) benefit of $ | ( | ( | ( | ||||||||||||||||||||||||||||||||
Balance as of September 30, 2026 | $ | ( | $ | ( | $ | ( | $ | $ | ( | $ | ( | ||||||||||||||||||||||||
| (In millions) | Net unrealized gains (losses) on investments with an allowance for credit losses | Net unrealized gains (losses) on other investments | Pension and postretirement benefits | Cumulative impact of changes in discount rates used to measure long duration contracts | Cumulative foreign currency translation adjustment | Total | |||||||||||||||||||||||||||||
Balance as of July 1, 2025 | $ | ( | $ | ( | $ | ( | $ | $ | ( | $ | ( | ||||||||||||||||||||||||
| Other comprehensive income (loss) before reclassifications | ( | ( | ( | ||||||||||||||||||||||||||||||||
Amounts reclassified from accumulated other comprehensive income (loss) net of tax (expense) benefit of $ | ( | ( | ( | ( | |||||||||||||||||||||||||||||||
Other comprehensive income (loss) net of tax (expense) benefit of $( | ( | ( | |||||||||||||||||||||||||||||||||
Balance as of September 30, 2025 | $ | ( | $ | ( | $ | ( | $ | $ | ( | $ | ( | ||||||||||||||||||||||||
34
Table of Contents
| (In millions) | Net unrealized gains (losses) on investments with an allowance for credit losses | Net unrealized gains (losses) on other investments | Pension and postretirement benefits | Cumulative impact of changes in discount rates used to measure long duration contracts | Cumulative foreign currency translation adjustment | Total | |||||||||||||||||||||||||||||
Balance as of January 1, 2026 | $ | ( | $ | ( | $ | ( | $ | $ | ( | $ | ( | ||||||||||||||||||||||||
| Other comprehensive income (loss) before reclassifications | ( | ( | ( | ( | ( | ||||||||||||||||||||||||||||||
Amounts reclassified from accumulated other comprehensive income (loss) net of tax (expense) benefit of $ | ( | ( | ( | ( | |||||||||||||||||||||||||||||||
Other comprehensive income (loss) net of tax (expense) benefit of $ | ( | ( | ( | ( | |||||||||||||||||||||||||||||||
Balance as of September 30, 2026 | $ | ( | $ | ( | $ | ( | $ | $ | ( | $ | ( | ||||||||||||||||||||||||
| (In millions) | Net unrealized gains (losses) on investments with an allowance for credit losses | Net unrealized gains (losses) on other investments | Pension and postretirement benefits | Cumulative impact of changes in discount rates used to measure long duration contracts | Cumulative foreign currency translation adjustment | Total | |||||||||||||||||||||||||||||
Balance as of January 1, 2025 | $ | ( | $ | ( | $ | ( | $ | $ | ( | $ | ( | ||||||||||||||||||||||||
| Other comprehensive income (loss) before reclassifications | ( | ( | |||||||||||||||||||||||||||||||||
Amounts reclassified from accumulated other comprehensive income (loss) net of tax (expense) benefit of $ | ( | ( | ( | ( | |||||||||||||||||||||||||||||||
Other comprehensive income (loss) net of tax (expense) benefit of $ | ( | ||||||||||||||||||||||||||||||||||
Balance as of September 30, 2025 | $ | ( | $ | ( | $ | ( | $ | $ | ( | $ | ( | ||||||||||||||||||||||||
Amounts reclassified from Accumulated other comprehensive income (loss) shown above are reported in Net income (loss) as follows:
| Component of AOCI | Condensed Consolidated Statements of Operations Line Item Affected by Reclassifications | |||||||
| Net unrealized gains (losses) on investments with an allowance for credit losses and Net unrealized gains (losses) on other investments | Net investment gains (losses) | |||||||
| Pension and postretirement benefits | Other operating expenses and Insurance claims and policyholders' benefits | |||||||
35
Table of Contents
Note J. Business Segments
The Company's property and casualty commercial insurance operations are managed and reported in three three segments are collectively referred to as Property & Casualty Operations. The Company's operations outside of Property & Casualty Operations are managed and reported in two segments: Life & Group and Corporate & Other.
The accounting policies of the segments are the same as those described in Note A to the Consolidated Financial Statements within CNAF's Annual Report on Form 10-K for the year ended December 31, 2025. The Company manages most of its assets on a legal entity basis, while segment operations are generally conducted across legal entities. As such, only Insurance and Reinsurance receivables, Insurance reserves, Deferred acquisition costs, Goodwill and Deferred non-insurance warranty acquisition expense and revenue are readily identifiable for individual segments. Distinct investment portfolios are not maintained for every individual segment; accordingly, allocation of assets to each segment is not performed. Therefore, a significant portion of Net investment income is allocated primarily based on each segment's net carried insurance reserves, as adjusted. All significant intersegment income and expense have been eliminated. Income taxes have been allocated on the basis of the taxable income of the segments.
In the following tables, certain financial measures are presented to provide information used by management to monitor the Company's operating performance. Management utilizes these financial measures to monitor the Company's insurance operations and investment portfolio.
The performance of the Company's insurance operations is monitored by management through core income (loss). The Company's Chief Operating Decision Maker (CODM) is the Chief Executive Officer. For all segments, the CODM uses a multi-year trend of core income (loss) to assess the segments' operating performance and make decisions regarding the allocation of resources to each segment.
Core income (loss) is calculated by excluding from net income (loss) the after-tax effects of net investment gains or losses and gains or losses resulting from pension settlement transactions. Net investment gains or losses are excluded from the calculation of core income (loss) because they are generally driven by economic factors that are not necessarily reflective of the Company's primary operations. The calculation of core income (loss) excludes gains or losses resulting from pension settlement transactions as they result from decisions regarding the Company's defined benefit pension plans which are unrelated to the Company's primary operations.
The Company's investment portfolio is monitored by management through analysis of various factors including unrealized gains and losses on securities, portfolio duration and exposure to market and credit risk.
36
Table of Contents
The Company's results of operations and selected balance sheet items by segment are presented in the following tables.
| Three months ended September 30, 2026 | Specialty | Commercial | International | Life & Group | Corporate & Other | ||||||||||||||||||||||||||||||||||||
| (In millions) | Eliminations | Total | |||||||||||||||||||||||||||||||||||||||
| Operating revenues | |||||||||||||||||||||||||||||||||||||||||
| Net earned premiums | $ | $ | $ | $ | $ | $ | ( | $ | |||||||||||||||||||||||||||||||||
| Net investment income | |||||||||||||||||||||||||||||||||||||||||
| Non-insurance warranty revenue | |||||||||||||||||||||||||||||||||||||||||
| Other revenues | ( | ||||||||||||||||||||||||||||||||||||||||
| Total operating revenues | ( | ||||||||||||||||||||||||||||||||||||||||
| Claims, benefits and expenses | |||||||||||||||||||||||||||||||||||||||||
| Net incurred claims and benefits | ( | ||||||||||||||||||||||||||||||||||||||||
| Policyholders’ dividends | |||||||||||||||||||||||||||||||||||||||||
| Amortization of deferred acquisition costs | |||||||||||||||||||||||||||||||||||||||||
| Non-insurance warranty expense | |||||||||||||||||||||||||||||||||||||||||
| Insurance related administrative expenses | ( | ||||||||||||||||||||||||||||||||||||||||
| Interest expense | |||||||||||||||||||||||||||||||||||||||||
Other segment items (1) | ( | ( | |||||||||||||||||||||||||||||||||||||||
| Total claims, benefits and expenses | ( | ||||||||||||||||||||||||||||||||||||||||
| Income tax (expense) benefit on core income (loss) | ( | ( | ( | ( | |||||||||||||||||||||||||||||||||||||
| Core income (loss) | $ | $ | $ | $ | ( | $ | ( | $ | $ | ||||||||||||||||||||||||||||||||
| Net investment gains (losses) | ( | ||||||||||||||||||||||||||||||||||||||||
| Income tax (expense) benefit on net investment gains (losses) | |||||||||||||||||||||||||||||||||||||||||
| Net investment gains (losses), after tax | ( | ||||||||||||||||||||||||||||||||||||||||
| Net income (loss) | $ | ||||||||||||||||||||||||||||||||||||||||
(1) Other segment items for the Company's property and casualty insurance segments reflects expenses not directly related to the Company's insurance operations, including certain expenses related to the Company's non-insurance warranty business within Specialty, claims services offerings within Commercial and foreign currency transaction gains and losses within International. Other segment items for the Corporate & Other segment reflects certain corporate expenses not attributable to the Company's ongoing property and casualty insurance operations.
37
Table of Contents
| Three months ended September 30, 2025 | Specialty | Commercial | International | Life & Group | Corporate & Other | ||||||||||||||||||||||||||||||||||||
| (In millions) | Eliminations | Total | |||||||||||||||||||||||||||||||||||||||
| Operating revenues | |||||||||||||||||||||||||||||||||||||||||
| Net earned premiums | $ | $ | $ | $ | $ | $ | ( | $ | |||||||||||||||||||||||||||||||||
| Net investment income | |||||||||||||||||||||||||||||||||||||||||
| Non-insurance warranty revenue | |||||||||||||||||||||||||||||||||||||||||
| Other revenues | ( | ||||||||||||||||||||||||||||||||||||||||
| Total operating revenues | ( | ||||||||||||||||||||||||||||||||||||||||
| Claims, benefits and expenses | |||||||||||||||||||||||||||||||||||||||||
| Net incurred claims and benefits | ( | ||||||||||||||||||||||||||||||||||||||||
| Policyholders’ dividends | |||||||||||||||||||||||||||||||||||||||||
| Amortization of deferred acquisition costs | |||||||||||||||||||||||||||||||||||||||||
| Non-insurance warranty expense | |||||||||||||||||||||||||||||||||||||||||
| Insurance related administrative expenses | ( | ||||||||||||||||||||||||||||||||||||||||
| Interest expense | |||||||||||||||||||||||||||||||||||||||||
Other segment items (1) | ( | ( | |||||||||||||||||||||||||||||||||||||||
| Total claims, benefits and expenses | ( | ||||||||||||||||||||||||||||||||||||||||
| Income tax (expense) benefit on core income (loss) | ( | ( | ( | ( | |||||||||||||||||||||||||||||||||||||
| Core income (loss) | $ | $ | $ | $ | ( | $ | ( | $ | $ | ||||||||||||||||||||||||||||||||
| Net investment gains (losses) | ( | ||||||||||||||||||||||||||||||||||||||||
| Income tax (expense) benefit on net investment gains (losses) | |||||||||||||||||||||||||||||||||||||||||
| Net investment gains (losses), after tax | ( | ||||||||||||||||||||||||||||||||||||||||
| Net income (loss) | $ | ||||||||||||||||||||||||||||||||||||||||
(1) Other segment items for the Company's property and casualty insurance segments reflects expenses not directly related to the Company's insurance operations, including certain expenses related to the Company's non-insurance warranty business within Specialty, claims services offerings within Commercial and foreign currency transaction gains and losses within International. Other segment items for the Corporate & Other segment reflects certain corporate expenses not attributable to the Company's ongoing property and casualty insurance operations.
38
Table of Contents
| Nine months ended September 30, 2026 | Specialty | Commercial | International | Life & Group | Corporate & Other | ||||||||||||||||||||||||||||||||||||
| (In millions) | Eliminations | Total | |||||||||||||||||||||||||||||||||||||||
| Operating revenues | |||||||||||||||||||||||||||||||||||||||||
| Net earned premiums | $ | $ | $ | $ | $ | $ | ( | $ | |||||||||||||||||||||||||||||||||
| Net investment income | |||||||||||||||||||||||||||||||||||||||||
| Non-insurance warranty revenue | |||||||||||||||||||||||||||||||||||||||||
| Other revenues | ( | ||||||||||||||||||||||||||||||||||||||||
| Total operating revenues | ( | ||||||||||||||||||||||||||||||||||||||||
| Claims, benefits and expenses | |||||||||||||||||||||||||||||||||||||||||
| Net incurred claims and benefits | |||||||||||||||||||||||||||||||||||||||||
| Policyholders’ dividends | |||||||||||||||||||||||||||||||||||||||||
| Amortization of deferred acquisition costs | |||||||||||||||||||||||||||||||||||||||||
| Non-insurance warranty expense | |||||||||||||||||||||||||||||||||||||||||
| Insurance related administrative expenses | ( | ||||||||||||||||||||||||||||||||||||||||
| Interest expense | |||||||||||||||||||||||||||||||||||||||||
Other segment items (1) | ( | ( | |||||||||||||||||||||||||||||||||||||||
| Total claims, benefits and expenses | ( | ||||||||||||||||||||||||||||||||||||||||
| Income tax (expense) benefit on core income (loss) | ( | ( | ( | ( | |||||||||||||||||||||||||||||||||||||
| Core income (loss) | $ | $ | $ | $ | ( | $ | ( | $ | $ | ||||||||||||||||||||||||||||||||
| Net investment gains (losses) | ( | ||||||||||||||||||||||||||||||||||||||||
| Income tax (expense) benefit on net investment gains (losses) | |||||||||||||||||||||||||||||||||||||||||
| Net investment gains (losses), after tax | ( | ||||||||||||||||||||||||||||||||||||||||
| Net income (loss) | $ | ||||||||||||||||||||||||||||||||||||||||
(1) Other segment items for the Company's property and casualty insurance segments reflects expenses not directly related to the Company's insurance operations, including certain expenses related to the Company's non-insurance warranty business within Specialty, claims services offerings within Commercial and foreign currency transaction gains and losses within International. Other segment items for the Corporate & Other segment reflects certain corporate expenses not attributable to the Company's ongoing property and casualty insurance operations.
39
Table of Contents
| September 30, 2026 | Specialty | Commercial | International | Life & Group | Corporate & Other | ||||||||||||||||||||||||||||||||||||
| (In millions) | Eliminations | Total | |||||||||||||||||||||||||||||||||||||||
| Reinsurance receivables | $ | $ | $ | $ | $ | $ | $ | ||||||||||||||||||||||||||||||||||
| Insurance receivables | |||||||||||||||||||||||||||||||||||||||||
| Deferred acquisition costs | |||||||||||||||||||||||||||||||||||||||||
| Goodwill | |||||||||||||||||||||||||||||||||||||||||
| Deferred non-insurance warranty acquisition expense | |||||||||||||||||||||||||||||||||||||||||
| Insurance reserves | |||||||||||||||||||||||||||||||||||||||||
| Claim and claim adjustment expenses | |||||||||||||||||||||||||||||||||||||||||
| Unearned premiums | |||||||||||||||||||||||||||||||||||||||||
| Future policy benefits | |||||||||||||||||||||||||||||||||||||||||
| Deferred non-insurance warranty revenue | |||||||||||||||||||||||||||||||||||||||||
40
Table of Contents
| Nine months ended September 30, 2025 | Specialty | Commercial | International | Life & Group | Corporate & Other | ||||||||||||||||||||||||||||||||||||
| (In millions) | Eliminations | Total | |||||||||||||||||||||||||||||||||||||||
| Operating revenues | |||||||||||||||||||||||||||||||||||||||||
| Net earned premiums | $ | $ | $ | $ | $ | $ | ( | $ | |||||||||||||||||||||||||||||||||
| Net investment income | |||||||||||||||||||||||||||||||||||||||||
| Non-insurance warranty revenue | |||||||||||||||||||||||||||||||||||||||||
| Other revenues | ( | ||||||||||||||||||||||||||||||||||||||||
| Total operating revenues | ( | ||||||||||||||||||||||||||||||||||||||||
| Claims, benefits and expenses | |||||||||||||||||||||||||||||||||||||||||
| Net incurred claims and benefits | |||||||||||||||||||||||||||||||||||||||||
| Policyholders’ dividends | |||||||||||||||||||||||||||||||||||||||||
| Amortization of deferred acquisition costs | |||||||||||||||||||||||||||||||||||||||||
| Non-insurance warranty expense | |||||||||||||||||||||||||||||||||||||||||
| Insurance related administrative expenses | ( | ||||||||||||||||||||||||||||||||||||||||
| Interest expense | |||||||||||||||||||||||||||||||||||||||||
Other segment items (1) | ( | ( | |||||||||||||||||||||||||||||||||||||||
| Total claims, benefits and expenses | ( | ||||||||||||||||||||||||||||||||||||||||
| Income tax (expense) benefit on core income (loss) | ( | ( | ( | ( | |||||||||||||||||||||||||||||||||||||
| Core income (loss) | $ | $ | $ | $ | ( | $ | ( | $ | $ | ||||||||||||||||||||||||||||||||
| Net investment gains (losses) | ( | ||||||||||||||||||||||||||||||||||||||||
| Income tax (expense) benefit on net investment gains (losses) | |||||||||||||||||||||||||||||||||||||||||
| Net investment gains (losses), after tax | ( | ||||||||||||||||||||||||||||||||||||||||
| Net income (loss) | $ | ||||||||||||||||||||||||||||||||||||||||
(1) Other segment items for the Company's property and casualty insurance segments reflects expenses not directly related to the Company's insurance operations, including certain expenses related to the Company's non-insurance warranty business within Specialty, claims services offerings within Commercial and foreign currency transaction gains and losses within International. Other segment items for the Corporate & Other segment reflects certain corporate expenses not attributable to the Company's ongoing property and casualty insurance operations.
41
Table of Contents
| December 31, 2025 | Specialty | Commercial | International | Life & Group | Corporate & Other | ||||||||||||||||||||||||||||||||||||
| (In millions) | Eliminations | Total | |||||||||||||||||||||||||||||||||||||||
| Reinsurance receivables | $ | $ | $ | $ | $ | $ | $ | ||||||||||||||||||||||||||||||||||
| Insurance receivables | |||||||||||||||||||||||||||||||||||||||||
| Deferred acquisition costs | |||||||||||||||||||||||||||||||||||||||||
| Goodwill | |||||||||||||||||||||||||||||||||||||||||
| Deferred non-insurance warranty acquisition expense | |||||||||||||||||||||||||||||||||||||||||
| Insurance reserves | |||||||||||||||||||||||||||||||||||||||||
| Claim and claim adjustment expenses | |||||||||||||||||||||||||||||||||||||||||
| Unearned premiums | |||||||||||||||||||||||||||||||||||||||||
| Future policy benefits | |||||||||||||||||||||||||||||||||||||||||
| Deferred non-insurance warranty revenue | |||||||||||||||||||||||||||||||||||||||||
42
Table of Contents
The following table presents further detail of significant segment expenses included within Net incurred claims and benefits for the Property & Casualty segments.
| Periods ended September 30 | Three Months | Nine Months | |||||||||||||||||||||
| (In millions) | 2026 | 2025 | 2026 | 2025 | |||||||||||||||||||
| Specialty | |||||||||||||||||||||||
| Non-catastrophe net incurred claim and claim adjustment expenses related to current year | $ | $ | $ | $ | |||||||||||||||||||
| Catastrophe losses | |||||||||||||||||||||||
(Favorable) unfavorable development (1) | |||||||||||||||||||||||
| Commercial | |||||||||||||||||||||||
| Non-catastrophe net incurred claim and claim adjustment expenses related to current year | $ | $ | $ | $ | |||||||||||||||||||
| Catastrophe losses | |||||||||||||||||||||||
(Favorable) unfavorable development (1) | ( | ||||||||||||||||||||||
| International | |||||||||||||||||||||||
| Non-catastrophe net incurred claim and claim adjustment expenses related to current year | $ | $ | $ | $ | |||||||||||||||||||
| Catastrophe losses | |||||||||||||||||||||||
(Favorable) unfavorable development (1) | ( | ( | |||||||||||||||||||||
(1) (Favorable) unfavorable development does not include the effects of interest accretion and change in allowance for uncollectible reinsurance.
The following table presents operating revenues by line of business for each reportable segment.
| Periods ended September 30 | Three Months | Nine Months | |||||||||||||||||||||
| (In millions) | 2026 | 2025 | 2026 | 2025 | |||||||||||||||||||
| Specialty | |||||||||||||||||||||||
| Management & Professional Liability | $ | $ | $ | $ | |||||||||||||||||||
| Surety | |||||||||||||||||||||||
| Warranty & Alternative Risks | |||||||||||||||||||||||
| Specialty revenues | |||||||||||||||||||||||
| Commercial | |||||||||||||||||||||||
Middle Market (1) | |||||||||||||||||||||||
Construction (1) | |||||||||||||||||||||||
| Small Business | |||||||||||||||||||||||
Other Commercial (1) | |||||||||||||||||||||||
| Commercial revenues | |||||||||||||||||||||||
| International | |||||||||||||||||||||||
| Canada | |||||||||||||||||||||||
| Europe | |||||||||||||||||||||||
| Hardy | |||||||||||||||||||||||
| International revenues | |||||||||||||||||||||||
| Life & Group revenues | |||||||||||||||||||||||
| Corporate & Other revenues | |||||||||||||||||||||||
| Eliminations | ( | ( | ( | ( | |||||||||||||||||||
| Total operating revenues | |||||||||||||||||||||||
| Net investment gains (losses) | ( | ( | ( | ( | |||||||||||||||||||
| Total revenues | $ | $ | $ | $ | |||||||||||||||||||
(1) Effective March 31, 2026, certain Commercial lines of businesses were realigned to reflect changes in management's responsibility for those businesses. Prior period information has been conformed to the new line of business presentation.
43
Table of Contents
Note K. Non-Insurance Revenues from Contracts with Customers
The Company had deferred non-insurance warranty revenue balances of $3.6 billion and $4.1 billion reported under Liabilities as of September 30, 2026 and December 31, 2025. For the three and nine months ended September 30, 2026, the Company recognized $0.2 billion and $0.8 billion of revenues that were included in the deferred revenue balance as of January 1, 2026. For the three and nine months ended September 30, 2025, the Company recognized $0.4 billion and $1.1 billion of revenues that were included in the deferred revenue balance as of January 1, 2025. For the three and nine months ended September 30, 2026 and 2025, non-insurance warranty revenue recognized from performance obligations related to prior periods due to a change in estimate was not material. The Company expects to recognize approximately $0.5 billion of the deferred revenue in the remainder of 2026, $1.0 billion in 2027, $0.8 billion in 2028 and $1.3 billion thereafter.
44
Table of Contents
Item 2. Management's Discussion and Analysis (MD&A) of Financial Condition and Results of Operations
OVERVIEW
The following discussion highlights significant factors affecting the Company. References to “we,” “our,” “us” or like terms refer to the business of CNA.
The following discussion should be read in conjunction with the Condensed Consolidated Financial Statements included under Part I, Item 1 of this Form 10-Q, and Item 1A Risk Factors and Item 7 Management's Discussion and Analysis of Financial Condition and Results of Operations, which are included in our Annual Report on Form 10-K filed with the Securities and Exchange Commission for the year ended December 31, 2025.
We utilize the core income (loss) financial measure to monitor our operations. Core income (loss) is calculated by excluding from net income (loss) the after-tax effects of net investment gains or losses and gains or losses resulting from pension settlement transactions. Net investment gains or losses are excluded from the calculation of core income (loss) because they are generally driven by economic factors that are not necessarily reflective of our primary operations. The calculation of core income (loss) excludes gains or losses resulting from pension settlement transactions as they result from decisions regarding our defined benefit pension plans which are unrelated to our primary operations. Presentation of consolidated core income (loss) is deemed to be a non-GAAP financial measure and management believes some investors may find this measure useful to evaluate our primary operations. See further discussion regarding how we manage our business in Note J to the Condensed Consolidated Financial Statements included under Part I, Item 1. For reconciliations of non-GAAP measures to the most comparable GAAP measures and other information, please refer herein and/or to our most recent Annual Report on Form 10-K on file with the Securities and Exchange Commission.
In evaluating the results of our Specialty, Commercial and International segments, we utilize the loss ratio, the underlying loss ratio, the expense ratio, the dividend ratio, the combined ratio and the underlying combined ratio. These ratios are calculated using GAAP financial results. The loss ratio is the percentage of net incurred claim and claim adjustment expenses to net earned premiums. The underlying loss ratio excludes the impact of catastrophe-related reinstatement premiums, catastrophe losses and development-related items from the loss ratio. Development-related items represent net prior year loss reserve and premium development, and include the effects of interest accretion and change in allowance for uncollectible reinsurance. The expense ratio is the percentage of insurance underwriting and acquisition expenses, including the amortization of deferred acquisition costs, to net earned premiums. The dividend ratio is the ratio of policyholders' dividends incurred to net earned premiums. The combined ratio is the sum of the loss ratio, the expense ratio and the dividend ratio. The underlying combined ratio is the sum of the underlying loss ratio, the expense ratio and the dividend ratio. The underlying loss ratio and the underlying combined ratio are deemed to be non-GAAP financial measures, and management believes some investors may find these ratios useful to evaluate our underwriting performance since they remove the impact of catastrophes which are unpredictable as to timing and amount, and development-related items as they are not indicative of our current year underwriting performance.
Changes in estimates of claim and claim adjustment expense reserves, net of reinsurance, for prior years are defined as net prior year loss reserve development within this MD&A. These changes can be favorable or unfavorable. Net prior year loss reserve development does not include the effect of any related acquisition expenses. Further information on our reserves is provided in Note E and Note F to the Condensed Consolidated Financial Statements included under Part I, Item 1.
In addition, we also utilize renewal premium change, rate, retention and new business in evaluating operating trends. Renewal premium change represents the estimated change in average premium on policies that renew, including rate and exposure changes. Rate represents the average change in price on policies that renew excluding exposure change. Exposure represents the measure of risk used in the pricing of the insurance product. The change in exposure represents the change in premium dollars on policies that renew as a result of the change in risk of the policy. Retention represents the percentage of premium dollars renewed, excluding rate and exposure changes, in comparison to the expiring premium dollars from policies available to renew. New business represents premiums from policies written with new customers and additional policies written with existing customers.
45
Table of Contents
We use underwriting gain (loss) and underlying underwriting gain (loss), calculated using GAAP financial results, to monitor our insurance operations. Underwriting gain (loss) is deemed to be a non-GAAP financial measure and is calculated pretax as net earned premiums less total insurance expenses, which includes insurance claims and policyholders' benefits, amortization of deferred acquisition costs and insurance related administrative expenses. Net income (loss) is the most directly comparable GAAP measure. Management believes some investors may find this measure useful to evaluate the profitability, before tax, derived from our underwriting activities, which are managed separately from our investing activities. Underlying underwriting gain (loss) is also deemed to be a non-GAAP financial measure, and represents pretax underwriting gain (loss) excluding catastrophe-related reinstatement premiums, catastrophe losses and development-related items. Management believes some investors may find this measure useful to evaluate the profitability, before tax, derived from our underwriting activities, excluding the impact of catastrophes, which are unpredictable as to timing and amount, and development-related items as they are not indicative of our current year underwriting performance.
The following tables present reconciliations of net income to core income, underwriting gain and underlying underwriting gain for our Property & Casualty Operations:
| Three months ended September 30, 2026 | Specialty | Commercial | International | Property & Casualty | ||||||||||||||||||||||||||||
| (In millions) | ||||||||||||||||||||||||||||||||
| Net income | $ | 143 | $ | 160 | $ | 88 | $ | 391 | ||||||||||||||||||||||||
| Net investment losses, after tax | 3 | 2 | 1 | 6 | ||||||||||||||||||||||||||||
| Core income | $ | 146 | $ | 162 | $ | 89 | $ | 397 | ||||||||||||||||||||||||
| Less: | ||||||||||||||||||||||||||||||||
| Net investment income | 150 | 204 | 48 | 402 | ||||||||||||||||||||||||||||
| Non-insurance warranty revenue (expense) | 18 | — | — | 18 | ||||||||||||||||||||||||||||
| Other revenue (expense), including interest expense | (13) | (5) | 14 | (4) | ||||||||||||||||||||||||||||
| Income tax expense on core income | (39) | (40) | (22) | (101) | ||||||||||||||||||||||||||||
| Underwriting gain | 30 | 3 | 49 | 82 | ||||||||||||||||||||||||||||
| Catastrophe-related reinstatement premiums | — | — | — | — | ||||||||||||||||||||||||||||
| Catastrophe losses | — | 70 | 8 | 78 | ||||||||||||||||||||||||||||
| Effect of unfavorable (favorable) development-related items | — | 35 | (35) | — | ||||||||||||||||||||||||||||
| Underlying underwriting gain | $ | 30 | $ | 108 | $ | 22 | $ | 160 | ||||||||||||||||||||||||
| Three months ended September 30, 2025 | Specialty | Commercial | International | Property & Casualty | ||||||||||||||||||||||||||||
| (In millions) | ||||||||||||||||||||||||||||||||
| Net income | $ | 173 | $ | 229 | $ | 44 | $ | 446 | ||||||||||||||||||||||||
| Net investment losses, after tax | 3 | 4 | 3 | 10 | ||||||||||||||||||||||||||||
| Core income | $ | 176 | $ | 233 | $ | 47 | $ | 456 | ||||||||||||||||||||||||
| Less: | ||||||||||||||||||||||||||||||||
| Net investment income | 162 | 192 | 42 | 396 | ||||||||||||||||||||||||||||
| Non-insurance warranty revenue (expense) | 16 | — | — | 16 | ||||||||||||||||||||||||||||
| Other revenue (expense), including interest expense | (15) | (3) | 1 | (17) | ||||||||||||||||||||||||||||
| Income tax expense on core income | (47) | (62) | (24) | (133) | ||||||||||||||||||||||||||||
| Underwriting gain | 60 | 106 | 28 | 194 | ||||||||||||||||||||||||||||
| Catastrophe-related reinstatement premiums | — | — | — | — | ||||||||||||||||||||||||||||
| Catastrophe losses | — | 39 | 2 | 41 | ||||||||||||||||||||||||||||
| Effect of development-related items | — | — | — | — | ||||||||||||||||||||||||||||
| Underlying underwriting gain | $ | 60 | $ | 145 | $ | 30 | $ | 235 | ||||||||||||||||||||||||
46
Table of Contents
| Nine months ended September 30, 2026 | Specialty | Commercial | International | Property & Casualty | |||||||||||||||||||||||||||||||
| (In millions) | |||||||||||||||||||||||||||||||||||
| Net income | $ | 395 | $ | 498 | $ | 160 | $ | 1,053 | |||||||||||||||||||||||||||
| Net investment losses, after tax | 7 | 8 | 3 | 18 | |||||||||||||||||||||||||||||||
| Core income | $ | 402 | $ | 506 | $ | 163 | $ | 1,071 | |||||||||||||||||||||||||||
| Less: | |||||||||||||||||||||||||||||||||||
| Net investment income | 463 | 640 | 135 | 1,238 | |||||||||||||||||||||||||||||||
| Non-insurance warranty revenue (expense) | 47 | — | — | 47 | |||||||||||||||||||||||||||||||
| Other revenue (expense), including interest expense | (39) | (10) | 12 | (37) | |||||||||||||||||||||||||||||||
| Income tax expense on core income | (107) | (128) | (57) | (292) | |||||||||||||||||||||||||||||||
| Underwriting gain | 38 | 4 | 73 | 115 | |||||||||||||||||||||||||||||||
| Catastrophe-related reinstatement premiums | — | 9 | — | 9 | |||||||||||||||||||||||||||||||
| Catastrophe losses | — | 207 | 19 | 226 | |||||||||||||||||||||||||||||||
| Effect of unfavorable (favorable) development-related items | 50 | 92 | (35) | 107 | |||||||||||||||||||||||||||||||
| Underlying underwriting gain | $ | 88 | $ | 312 | $ | 57 | $ | 457 | |||||||||||||||||||||||||||
| Nine months ended September 30, 2025 | Specialty | Commercial | International | Property & Casualty | |||||||||||||||||||||||||||||||
| (In millions) | |||||||||||||||||||||||||||||||||||
| Net income | $ | 487 | $ | 552 | $ | 135 | $ | 1,174 | |||||||||||||||||||||||||||
| Net investment losses, after tax | 16 | 23 | 2 | 41 | |||||||||||||||||||||||||||||||
| Core income | $ | 503 | $ | 575 | $ | 137 | $ | 1,215 | |||||||||||||||||||||||||||
| Less: | |||||||||||||||||||||||||||||||||||
| Net investment income | 483 | 575 | 114 | 1,172 | |||||||||||||||||||||||||||||||
| Non-insurance warranty revenue (expense) | 42 | — | — | 42 | |||||||||||||||||||||||||||||||
| Other revenue (expense), including interest expense | (40) | (10) | 12 | (38) | |||||||||||||||||||||||||||||||
| Income tax expense on core income | (137) | (153) | (55) | (345) | |||||||||||||||||||||||||||||||
| Underwriting gain | 155 | 163 | 66 | 384 | |||||||||||||||||||||||||||||||
| Catastrophe-related reinstatement premiums | — | — | — | — | |||||||||||||||||||||||||||||||
| Catastrophe losses | — | 182 | 18 | 200 | |||||||||||||||||||||||||||||||
| Effect of unfavorable development-related items | 10 | 54 | — | 64 | |||||||||||||||||||||||||||||||
| Underlying underwriting gain | $ | 165 | $ | 399 | $ | 84 | $ | 648 | |||||||||||||||||||||||||||
The following table presents a reconciliation of net loss to core loss for our Life & Group segment:
| Periods ended September 30 | Three Months | Nine Months | |||||||||||||||||||||
| (In millions) | 2026 | 2025 | 2026 | 2025 | |||||||||||||||||||
| Net loss | $ | (173) | $ | (17) | $ | (196) | $ | (22) | |||||||||||||||
| Net investment losses (gains), after tax | 2 | (5) | 6 | 7 | |||||||||||||||||||
| Core loss | $ | (171) | $ | (22) | $ | (190) | $ | (15) | |||||||||||||||
The following table presents a reconciliation of net loss to core loss for our Corporate & Other segment:
| Periods ended September 30 | Three Months | Nine Months | |||||||||||||||||||||
| (In millions) | 2026 | 2025 | 2026 | 2025 | |||||||||||||||||||
| Net loss | $ | (22) | $ | (26) | $ | (129) | $ | (176) | |||||||||||||||
| Net investment (gains) losses, after tax | (1) | 1 | — | 1 | |||||||||||||||||||
| Core loss | $ | (23) | $ | (25) | $ | (129) | $ | (175) | |||||||||||||||
47
Table of Contents
CRITICAL ACCOUNTING ESTIMATES
The preparation of the Condensed Consolidated Financial Statements in conformity with GAAP requires us to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the Condensed Consolidated Financial Statements and the amount of revenues and expenses reported during the period. Actual results may differ from those estimates.
Our Condensed Consolidated Financial Statements and accompanying notes have been prepared in accordance with GAAP applied on a consistent basis. We continually evaluate the accounting policies and estimates used to prepare the Condensed Consolidated Financial Statements. In general, our estimates are based on historical experience, evaluation of current trends, information from third-party professionals and various other assumptions that are believed to be reasonable under the known facts and circumstances.
The accounting estimates set forth below are considered by us to be critical to an understanding of our Condensed Consolidated Financial Statements as their application places the most significant demands on our judgment:
•Insurance Reserves
•Long-Term Care Reserves
•Valuation of Investments and Impairment of Securities
Due to the inherent uncertainties involved with these types of judgments, actual results could differ significantly from our estimates and may have a material adverse impact on our results of operations, financial condition, equity, business, and insurer financial strength and corporate debt ratings. See the Critical Accounting Estimates section of our Management's Discussion and Analysis of Financial Condition and Results of Operations included under Item 7 of our Annual Report on Form 10-K for the year ended December 31, 2025 for further information.
48
Table of Contents
CONSOLIDATED OPERATIONS
Results of Operations
The following table includes the consolidated results of our operations including our financial measure, core income (loss). For more detailed components of our business operations and a discussion of the core income (loss) financial measure, see the Segment Results section within this MD&A. For further discussion of Net investment income and Net investment gains or losses, see the Investments section of this MD&A.
| Periods ended September 30 | Three Months | Nine Months | |||||||||||||||||||||
| (In millions) | 2026 | 2025 | 2026 | 2025 | |||||||||||||||||||
| Operating Revenues | |||||||||||||||||||||||
| Net earned premiums | $ | 2,831 | $ | 2,783 | $ | 8,291 | $ | 8,103 | |||||||||||||||
| Net investment income | 635 | 638 | 1,946 | 1,904 | |||||||||||||||||||
| Non-insurance warranty revenue | 357 | 393 | 1,098 | 1,188 | |||||||||||||||||||
| Other revenues | 7 | 10 | 24 | 28 | |||||||||||||||||||
| Total operating revenues | 3,830 | 3,824 | 11,359 | 11,223 | |||||||||||||||||||
| Claims, Benefits and Expenses | |||||||||||||||||||||||
Net incurred claims and benefits (re-measurement loss of $222, $36, $266 and $59) | 2,336 | 2,023 | 6,659 | 6,115 | |||||||||||||||||||
| Policyholders' dividends | 11 | 9 | 32 | 29 | |||||||||||||||||||
| Amortization of deferred acquisition costs | 492 | 483 | 1,449 | 1,423 | |||||||||||||||||||
| Non-insurance warranty expense | 339 | 377 | 1,051 | 1,146 | |||||||||||||||||||
| Insurance related administrative expenses | 349 | 324 | 1,024 | 982 | |||||||||||||||||||
| Interest expense | 32 | 36 | 98 | 99 | |||||||||||||||||||
| Other expenses | 25 | 52 | 105 | 125 | |||||||||||||||||||
| Total claims, benefits and expenses | 3,584 | 3,304 | 10,418 | 9,919 | |||||||||||||||||||
| Income tax expense on core income | (43) | (111) | (189) | (279) | |||||||||||||||||||
| Core income | 203 | 409 | 752 | 1,025 | |||||||||||||||||||
| Net investment losses | (9) | (7) | (32) | (62) | |||||||||||||||||||
| Income tax benefit on net investment losses | 2 | 1 | 8 | 13 | |||||||||||||||||||
| Net investment losses, after tax | (7) | (6) | (24) | (49) | |||||||||||||||||||
| Net income | $ | 196 | $ | 403 | $ | 728 | $ | 976 | |||||||||||||||
Three Month Comparison
Core income decreased $206 million for the three months ended September 30, 2026 as compared with the same period in 2025. Core income for our Property & Casualty Operations decreased $59 million primarily driven by lower underlying underwriting results and higher catastrophe losses. Core results for our Life & Group segment decreased $149 million as a result of the annual reserve review, while core loss for our Corporate & Other segment improved $2 million.
Catastrophe losses were $78 million and $41 million for the three months ended September 30, 2026 and 2025 driven by severe weather related events. There were no catastrophe-related reinsurance reinstatement premiums for the three months ended September 30, 2026 or 2025. Favorable net prior year loss reserve development of $1 million was recorded for the three months ended September 30, 2026 and 2025 related to our Commercial and International segments. Further information on net prior year loss reserve development is in Note E to the Condensed Consolidated Financial Statements included under Part I, Item 1.
49
Table of Contents
Nine Month Comparison
Core income decreased $273 million for the nine months ended September 30, 2026 as compared with the same period in 2025. Core income for our Property & Casualty Operations decreased $144 million primarily driven by lower underlying underwriting results, higher unfavorable net prior year loss reserve development and higher catastrophe losses, partially offset by higher net investment income. Core results for our Life & Group segment decreased $175 million as a result of the annual reserve review, while core loss for our Corporate & Other segment improved $46 million.
Catastrophe losses were $226 million and catastrophe-related reinsurance reinstatement premiums were $9 million for the nine months ended September 30, 2026 driven by severe weather related events. Catastrophe losses were $200 million for the nine months ended September 30, 2025 driven by severe weather related events. There were no catastrophe-related reinsurance reinstatement premiums for the nine months ended September 30, 2025. Unfavorable net prior year loss reserve development of $190 million was recorded for each of the nine months ended September 30, 2026 and 2025 related to our Specialty, Commercial, International and Corporate & Other segments. Further information on net prior year loss reserve development is in Note E to the Condensed Consolidated Financial Statements included under Part I, Item 1.
50
Table of Contents
SEGMENT RESULTS
The following discusses the results of operations for our business segments. Our property and casualty commercial insurance operations are managed and reported in three business segments: Specialty, Commercial and International, which we refer to collectively as Property & Casualty Operations. Our operations outside of Property & Casualty Operations are managed and reported in two segments: Life & Group and Corporate & Other.
51
Table of Contents
Specialty
The following table details the results of operations for Specialty and provides the components to reconcile the combined ratio and loss ratio to the underlying combined ratio and underlying loss ratio.
| Periods ended September 30 | Three Months | Nine Months | |||||||||||||||||||||
| (In millions, except ratios, rate, renewal premium change and retention) | 2026 | 2025 | 2026 | 2025 | |||||||||||||||||||
| Net written premiums | $ | 900 | $ | 867 | $ | 2,671 | $ | 2,601 | |||||||||||||||
| Net earned premiums | 907 | 881 | 2,637 | 2,573 | |||||||||||||||||||
| Underwriting gain | 30 | 60 | 38 | 155 | |||||||||||||||||||
| Net investment income | 150 | 162 | 463 | 483 | |||||||||||||||||||
| Core income | 146 | 176 | 402 | 503 | |||||||||||||||||||
| Other performance metrics: | |||||||||||||||||||||||
| Loss ratio | 62.9 | % | 60.6 | % | 64.7 | % | 60.7 | % | |||||||||||||||
| Expense ratio | 33.6 | 32.5 | 33.5 | 33.0 | |||||||||||||||||||
| Dividend ratio | 0.3 | 0.2 | 0.4 | 0.3 | |||||||||||||||||||
| Combined ratio | 96.8 | % | 93.3 | % | 98.6 | % | 94.0 | % | |||||||||||||||
| Less: Effect of catastrophe impacts | 0.1 | — | — | — | |||||||||||||||||||
| Less: Effect of unfavorable development-related items | — | — | 1.9 | 0.4 | |||||||||||||||||||
| Underlying combined ratio | 96.7 | % | 93.3 | % | 96.7 | % | 93.6 | % | |||||||||||||||
| Underlying loss ratio | 62.8 | % | 60.6 | % | 62.8 | % | 60.3 | % | |||||||||||||||
| Rate | 4 | % | 3 | % | 4 | % | 3 | % | |||||||||||||||
| Renewal premium change | 5 | 4 | 5 | 4 | |||||||||||||||||||
| Retention | 83 | 86 | 84 | 87 | |||||||||||||||||||
| New business | $ | 137 | $ | 131 | $ | 439 | $ | 365 | |||||||||||||||
Three Month Comparison
Net written premiums for Specialty increased $33 million for the three months ended September 30, 2026 as compared with the same period in 2025 driven by rate and higher new business. The increase in net earned premiums was consistent with the trend in net written premiums.
Core income decreased $30 million for the three months ended September 30, 2026 as compared with the same period in 2025 primarily due to lower underlying underwriting results and lower net investment income.
The combined ratio of 96.8% increased 3.5 points for the three months ended September 30, 2026 as compared with the same period in 2025 primarily due to a 2.3 point increase in the loss ratio and a 1.1 point increase in the expense ratio. The increase in the loss ratio reflected a higher underlying loss ratio across various lines. The underlying loss ratio was consistent with the first half of 2026. The increase in the expense ratio was primarily driven by higher acquisition costs. Catastrophe losses were less than $1 million, or 0.1 points of the loss ratio, for the three months ended September 30, 2026 as compared with no catastrophe losses for the three months ended September 30, 2025.
52
Table of Contents
Nine Month Comparison
Net written premiums for Specialty increased $70 million for the nine months ended September 30, 2026 as compared with the same period in 2025 driven by higher new business and rate partially offset by lower retention. The increase in net earned premiums was consistent with the trend in net written premiums.
Core income decreased $101 million for the nine months ended September 30, 2026 as compared with the same period in 2025 primarily due to lower underlying underwriting results, higher unfavorable net prior year loss reserve development and lower net investment income.
The combined ratio of 98.6% increased 4.6 points for the nine months ended September 30, 2026 as compared with the same period in 2025 primarily due to a 4.0 point increase in the loss ratio and a 0.5 point increase in the expense ratio. The increase in the loss ratio reflected both a higher underlying loss ratio across various lines and higher unfavorable net prior year loss reserve development. The increase in the expense ratio was primarily driven by higher acquisition costs. Catastrophe losses were less than $1 million for the nine months ended September 30, 2026. There were no catastrophe losses for the nine months ended September 30, 2025.
Unfavorable net prior year loss reserve development of $44 million and $10 million was recorded for the nine months ended September 30, 2026 and 2025. Further information on net prior year loss reserve development is in Note E to the Condensed Consolidated Financial Statements included under Part I, Item 1.
The following table summarizes the gross and net carried reserves for Specialty.
| (In millions) | September 30, 2026 | December 31, 2025 | |||||||||
| Gross case reserves | $ | 2,178 | $ | 2,166 | |||||||
| Gross IBNR reserves | 5,964 | 5,618 | |||||||||
| Total gross carried claim and claim adjustment expense reserves | $ | 8,142 | $ | 7,784 | |||||||
| Net case reserves | $ | 1,816 | $ | 1,801 | |||||||
| Net IBNR reserves | 4,710 | 4,387 | |||||||||
| Total net carried claim and claim adjustment expense reserves | $ | 6,526 | $ | 6,188 | |||||||
53
Table of Contents
Commercial
The following table details the results of operations for Commercial and provides the components to reconcile the combined ratio and loss ratio to the underlying combined ratio and underlying loss ratio.
| Periods ended September 30 | Three Months | Nine Months | |||||||||||||||||||||
| (In millions, except ratios, rate, renewal premium change and retention) | 2026 | 2025 | 2026 | 2025 | |||||||||||||||||||
| Net written premiums | $ | 1,274 | $ | 1,251 | $ | 4,397 | $ | 4,312 | |||||||||||||||
| Net earned premiums | 1,475 | 1,453 | 4,328 | 4,235 | |||||||||||||||||||
| Underwriting gain | 3 | 106 | 4 | 163 | |||||||||||||||||||
| Net investment income | 204 | 192 | 640 | 575 | |||||||||||||||||||
| Core income | 162 | 233 | 506 | 575 | |||||||||||||||||||
| Other performance metrics: | |||||||||||||||||||||||
| Loss ratio | 73.0 | % | 66.1 | % | 72.9 | % | 68.7 | % | |||||||||||||||
| Expense ratio | 26.2 | 26.1 | 26.5 | 26.9 | |||||||||||||||||||
| Dividend ratio | 0.5 | 0.5 | 0.5 | 0.5 | |||||||||||||||||||
| Combined ratio | 99.7 | % | 92.7 | % | 99.9 | % | 96.1 | % | |||||||||||||||
| Less: Effect of catastrophe impacts | 4.8 | 2.7 | 5.0 | 4.3 | |||||||||||||||||||
| Less: Effect of unfavorable development-related items | 2.4 | — | 2.1 | 1.3 | |||||||||||||||||||
| Underlying combined ratio | 92.5 | % | 90.0 | % | 92.8 | % | 90.5 | % | |||||||||||||||
| Underlying loss ratio | 65.8 | % | 63.4 | % | 65.8 | % | 63.1 | % | |||||||||||||||
| Rate | 2 | % | 5 | % | 1 | % | 5 | % | |||||||||||||||
| Renewal premium change | 3 | 6 | 3 | 7 | |||||||||||||||||||
| Retention | 83 | 79 | 81 | 82 | |||||||||||||||||||
| New business | $ | 332 | $ | 324 | $ | 1,147 | $ | 1,114 | |||||||||||||||
Three Month Comparison
Net written premiums for Commercial increased $23 million for the three months ended September 30, 2026 as compared with the same period in 2025 driven by rate and higher new business. The increase in net earned premiums was consistent with the trend in net written premiums.
Core income decreased $71 million for the three months ended September 30, 2026 as compared with the same period in 2025 driven by lower underlying underwriting results, unfavorable net prior year loss reserve development and higher catastrophe losses, partially offset by higher net investment income.
The combined ratio of 99.7% increased 7.0 points for the three months ended September 30, 2026 as compared with the same period in 2025 primarily due to a 6.9 point increase in the loss ratio. The increase in the loss ratio reflected a higher underlying loss ratio in excess casualty and workers' compensation, unfavorable net prior year loss reserve development and higher catastrophe losses. The underlying loss ratio was consistent with the first half of 2026. Catastrophe losses were $70 million, or 4.8 points of the loss ratio, for the three months ended September 30, 2026 as compared with $39 million, or 2.7 points of the loss ratio, for the three months ended September 30, 2025. The expense ratio was generally consistent with the same period in 2025.
Unfavorable net prior year loss reserve development of $34 million was recorded for the three months ended September 30, 2026 as compared with $1 million of favorable net prior year loss reserve development recorded for the three months ended September 30, 2025. Further information on net prior year loss reserve development is in Note E to the Condensed Consolidated Financial Statements included under Part I, Item 1.
54
Table of Contents
Nine Month Comparison
Net written premiums for Commercial increased $85 million for the nine months ended September 30, 2026 as compared with the same period in 2025 driven by rate and higher new business. The increase in net earned premiums was consistent with the trend in net written premiums.
Core income decreased $69 million for the nine months ended September 30, 2026 as compared with the same period in 2025 due to lower underlying underwriting results, higher unfavorable net prior year loss reserve development and higher catastrophe losses, partially offset by higher net investment income.
The combined ratio of 99.9% increased 3.8 points for the nine months ended September 30, 2026 as compared with the same period in 2025 due to a 4.2 point increase in the loss ratio partially offset by a 0.4 point improvement in the expense ratio. The increase in the loss ratio was driven by a higher underlying loss ratio in excess casualty and workers' compensation, higher unfavorable net prior year loss reserve development and higher catastrophe losses. Catastrophe losses were $207 million for the nine months ended September 30, 2026 as compared with $182 million for the nine months ended September 30, 2025. The current year also includes $9 million of catastrophe-related reinsurance reinstatement premiums. The effect of catastrophe impacts on the loss ratio was 5.0 points for the nine months ended September 30, 2026 as compared with 4.3 points for the nine months ended September 30, 2025. The improvement in the expense ratio was primarily driven by lower acquisition costs.
Unfavorable net prior year loss reserve development of $84 million and $46 million was recorded for the nine months ended September 30, 2026 and 2025. Further information on net prior year loss reserve development is in Note E to the Condensed Consolidated Financial Statements included under Part I, Item 1.
The following table summarizes the gross and net carried reserves for Commercial.
| (In millions) | September 30, 2026 | December 31, 2025 | |||||||||
| Gross case reserves | $ | 4,218 | $ | 4,093 | |||||||
| Gross IBNR reserves | 9,040 | 8,156 | |||||||||
| Total gross carried claim and claim adjustment expense reserves | $ | 13,258 | $ | 12,249 | |||||||
| Net case reserves | $ | 3,662 | $ | 3,508 | |||||||
| Net IBNR reserves | 7,803 | 7,188 | |||||||||
| Total net carried claim and claim adjustment expense reserves | $ | 11,465 | $ | 10,696 | |||||||
55
Table of Contents
International
The following table details the results of operations for International and provides the components to reconcile the combined ratio and loss ratio to the underlying combined ratio and underlying loss ratio.
| Periods ended September 30 | Three Months | Nine Months | |||||||||||||||||||||
| (In millions, except ratios, rate, renewal premium change and retention) | 2026 | 2025 | 2026 | 2025 | |||||||||||||||||||
| Net written premiums | $ | 333 | $ | 319 | $ | 1,026 | $ | 976 | |||||||||||||||
| Net earned premiums | 349 | 344 | 1,020 | 978 | |||||||||||||||||||
| Underwriting gain | 49 | 28 | 73 | 66 | |||||||||||||||||||
| Net investment income | 48 | 42 | 135 | 114 | |||||||||||||||||||
| Core income | 89 | 47 | 163 | 137 | |||||||||||||||||||
| Other performance metrics: | |||||||||||||||||||||||
| Loss ratio | 51.8 | % | 59.1 | % | 58.2 | % | 60.3 | % | |||||||||||||||
| Expense ratio | 34.3 | 32.7 | 34.7 | 32.9 | |||||||||||||||||||
| Combined ratio | 86.1 | % | 91.8 | % | 92.9 | % | 93.2 | % | |||||||||||||||
| Less: Effect of catastrophe impacts | 2.1 | 0.6 | 1.8 | 1.8 | |||||||||||||||||||
| Less: Effect of favorable development-related items | (10.1) | — | (3.4) | — | |||||||||||||||||||
| Underlying combined ratio | 94.1 | % | 91.2 | % | 94.5 | % | 91.4 | % | |||||||||||||||
| Underlying loss ratio | 59.8 | % | 58.5 | % | 59.8 | % | 58.5 | % | |||||||||||||||
| Rate | (4) | % | (6) | % | (5) | % | (4) | % | |||||||||||||||
| Renewal premium change | (2) | (3) | (2) | (1) | |||||||||||||||||||
| Retention | 87 | 83 | 86 | 85 | |||||||||||||||||||
| New business | $ | 86 | $ | 94 | $ | 268 | $ | 280 | |||||||||||||||
Three Month Comparison
Net written premiums for International increased $14 million for the three months ended September 30, 2026 as compared with the same period in 2025. Excluding the effect of foreign currency exchange rates, net written premiums increased $18 million as compared with the same period in 2025 driven by higher retention partially offset by lower rate. The increase in net earned premiums was consistent with the trend in net written premiums.
Core income increased $42 million for the three months ended September 30, 2026 as compared with the same period in 2025, primarily driven by favorable net prior year loss reserve development in the current period compared with no net prior year loss reserve development in the prior year period.
The combined ratio of 86.1% improved 5.7 points for the three months ended September 30, 2026 as compared with the same period in 2025 due to a 7.3 point improvement in the loss ratio partially offset by a 1.6 point increase in the expense ratio. The improvement in the loss ratio was due to $35 million of favorable net prior year loss reserve development in the three months ended September 30, 2026 compared with no net prior year loss reserve development in the same period in 2025, partially offset by higher catastrophe losses and an increase in the underlying loss ratio across most lines. The underlying loss ratio was consistent with the first half of 2026. Catastrophe losses were $8 million, or 2.1 points of the loss ratio, for the three months ended September 30, 2026, as compared with $2 million, or 0.6 points of the loss ratio, for the three months ended September 30, 2025. The increase in the expense ratio reflects higher acquisition costs.
Further information on net prior year loss reserve development is in Note E to the Condensed Consolidated Financial Statements included under Part I, Item 1.
56
Table of Contents
Nine Month Comparison
Net written premiums for International increased $50 million for the nine months ended September 30, 2026 as compared with the same period in 2025. Excluding the effect of foreign currency exchange rates, net written premiums increased $26 million as compared with the same period in 2025 driven by higher retention partially offset by lower rate. The increase in net earned premiums was consistent with the trend in net written premiums.
Core income increased $26 million for the nine months ended September 30, 2026 as compared with the same period in 2025, driven by favorable net prior year loss reserve development in the current period compared with no development in the prior year period and higher net investment income, partially offset by lower underlying underwriting results.
The combined ratio of 92.9% improved 0.3 points for the nine months ended September 30, 2026 as compared with the same period in 2025 due to a 2.1 point improvement in the loss ratio largely offset by a 1.8 point increase in the expense ratio. The improvement in the loss ratio was primarily due to $35 million of favorable net prior year loss reserve development in the nine months ended September 30, 2026 compared with no net prior year loss reserve development in the same period in 2025, partially offset by an increase in the underlying loss ratio across most lines. Catastrophe losses were $19 million, or 1.8 points of the loss ratio, for the nine months ended September 30, 2026, as compared with $18 million, or 1.8 points of the loss ratio, for the nine months ended September 30, 2025. The increase in the expense ratio was primarily driven by continued investments in talent and technology and higher acquisition costs, partially offset by higher net earned premiums.
Further information on net prior year loss reserve development is in Note E to the Condensed Consolidated Financial Statements included under Part I, Item 1.
The following table summarizes the gross and net carried reserves for International.
| (In millions) | September 30, 2026 | December 31, 2025 | |||||||||
| Gross case reserves | $ | 1,108 | $ | 1,052 | |||||||
| Gross IBNR reserves | 2,441 | 2,324 | |||||||||
| Total gross carried claim and claim adjustment expense reserves | $ | 3,549 | $ | 3,376 | |||||||
| Net case reserves | $ | 910 | $ | 880 | |||||||
| Net IBNR reserves | 2,072 | 1,961 | |||||||||
| Total net carried claim and claim adjustment expense reserves | $ | 2,982 | $ | 2,841 | |||||||
57
Table of Contents
Life & Group
The following table summarizes the results of operations for Life & Group.
| Periods ended September 30 | Three Months | Nine Months | |||||||||||||||||||||
| (In millions) | 2026 | 2025 | 2026 | 2025 | |||||||||||||||||||
| Net earned premiums | $ | 101 | $ | 106 | $ | 307 | $ | 318 | |||||||||||||||
| Claims, benefits and expenses | 547 | 365 | 1,241 | 1,040 | |||||||||||||||||||
| Net investment income | 223 | 226 | 677 | 687 | |||||||||||||||||||
| Core loss | (171) | (22) | (190) | (15) | |||||||||||||||||||
Three Month Comparison
Core results decreased $149 million for the three months ended September 30, 2026 as compared with the same period in 2025. Both periods include assumption updates as a result of the annual reserve reviews.
The cash flow assumption updates from the annual reserve review for the three months ended September 30, 2026 resulted in a pretax increase in long-term care reserves of $173 million primarily driven by unfavorable cost of care inflation and morbidity impacts, partially offset by favorable premium rate actions. However, the unfavorable expected cash flows from the reserve assumption updates are almost entirely offset by a favorable economic impact from anticipated future investment cash flows from recent investment portfolio actions. Under GAAP accounting, the anticipated benefits of these portfolio actions are not immediately reflected in earnings, but instead are recognized through net investment income over time.
The cash flow assumption updates from the annual reserve review for the three months ended September 30, 2025 resulted in a pretax increase in long-term care reserves of $7 million.
Nine Month Comparison
Results for the nine months ended September 30, 2026 were generally consistent with the three month summary above.
Future Policy Benefit Reserves
Annually in the third quarter, an actuarial analysis is performed on policyholder morbidity, persistency, premium rate actions and expense experience. This analysis, combined with judgment, informs the setting of updated cash flow assumptions used to estimate the liability for future policyholder benefits (LFPB). See Note A to the Consolidated Financial Statements within CNAF's Annual Report on Form 10-K for the year ended December 31, 2025 for further information on the long-term care reserving process.
The table below summarizes the estimated pretax impact on our results of operations from various hypothetical revisions to our LFPB reserve assumptions. We have assumed that revisions to such assumptions would occur in each policy type, age and duration within each long-term care product. The impact of each sensitivity is discrete and does not reflect the impact one factor may have on another or the mitigating impact from management actions, which may include additional future premium rate increases. Although such hypothetical revisions are not currently required or anticipated, we believe they could occur based on past variances in experience and our expectations of the ranges of future experience that could reasonably occur. Any actual adjustment would be dependent on the specific policies affected and, therefore, may differ from the estimates summarized below. The estimated impacts to results of operations in the table below are after consideration of any net premium ratio impacts.
58
Table of Contents
| September 30, 2026 | |||||
| Estimated reduction to pretax income | |||||
| Hypothetical revisions (In millions) | |||||
| Morbidity: | |||||
| 2.5% increase in morbidity | $ | 320 | |||
| 5% increase in morbidity | 640 | ||||
| Persistency: | |||||
| 5% decrease in active life mortality and lapse | $ | 190 | |||
| 10% decrease in active life mortality and lapse | 380 | ||||
| Premium Rate Actions: | |||||
| 25% decrease in future unapproved rate increase premium | $ | 30 | |||
| 50% decrease in future unapproved rate increase premium | 60 | ||||
The following table summarizes policyholder reserves for Life & Group.
| September 30, 2026 | |||||||||||||||||
| (In millions) | Claim and claim adjustment expenses | Future policy benefits | Total | ||||||||||||||
| Long-term care | $ | — | $ | 12,437 | $ | 12,437 | |||||||||||
| Structured settlements and other | 486 | — | 486 | ||||||||||||||
| Total | 486 | 12,437 | 12,923 | ||||||||||||||
| Ceded reserves | 53 | — | 53 | ||||||||||||||
| Total gross reserves | $ | 539 | $ | 12,437 | $ | 12,976 | |||||||||||
| December 31, 2025 | |||||||||||||||||
| (In millions) | Claim and claim adjustment expenses | Future policy benefits | Total | ||||||||||||||
| Long-term care | $ | — | $ | 13,448 | $ | 13,448 | |||||||||||
| Structured settlements and other | 535 | — | 535 | ||||||||||||||
| Total | 535 | 13,448 | 13,983 | ||||||||||||||
| Ceded reserves | 56 | — | 56 | ||||||||||||||
| Total gross reserves | $ | 591 | $ | 13,448 | $ | 14,039 | |||||||||||
As part of the annual reserve review, statutory long-term care reserve adequacy is evaluated via premium deficiency testing, by comparing statutory policy level reserves on a carried basis with our best estimate reserves, which incorporates best estimate discount rate and liability assumptions in its determination. Statutory margin is the excess of policy level reserves on a carried basis over the corresponding reserves determined on a best estimate basis. As of September 30, 2026, our statutory long-term care margin was $1.3 billion.
59
Table of Contents
Corporate & Other
The following table summarizes the results of operations for the Corporate & Other segment, including intersegment eliminations.
| Periods ended September 30 | Three Months | Nine Months | |||||||||||||||||||||
| (In millions) | 2026 | 2025 | 2026 | 2025 | |||||||||||||||||||
| Net investment income | $ | 10 | $ | 16 | $ | 31 | $ | 45 | |||||||||||||||
| Insurance claims and policyholders' benefits | (6) | (10) | 54 | 107 | |||||||||||||||||||
| Interest expense | 32 | 36 | 98 | 99 | |||||||||||||||||||
| Core loss | (23) | (25) | (129) | (175) | |||||||||||||||||||
Three Month Comparison
Core loss improved $2 million for the three months ended September 30, 2026 as compared with the same period in 2025.
Nine Month Comparison
Core loss improved $46 million for the nine months ended September 30, 2026 as compared with the same period in 2025. The current period includes a $77 million after-tax charge related to unfavorable net prior year loss reserve development largely associated with legacy mass tort abuse reserves as compared with a $106 million after-tax charge in the prior year period. The current period also includes an increase of $14 million after-tax associated with the amortization of the deferred gain related to the A&EP LPT as compared to the prior year period.
Further information on the net prior year loss reserve development and the A&EP LPT is in Note E to the Condensed Consolidated Financial Statements included under Part I, Item 1.
The following table summarizes the gross and net carried reserves for Corporate & Other.
| (In millions) | September 30, 2026 | December 31, 2025 | |||||||||
| Gross case reserves | $ | 1,215 | $ | 1,196 | |||||||
| Gross IBNR reserves | 1,214 | 1,403 | |||||||||
| Total gross carried claim and claim adjustment expense reserves | $ | 2,429 | $ | 2,599 | |||||||
| Net case reserves | $ | 132 | $ | 119 | |||||||
| Net IBNR reserves | 261 | 238 | |||||||||
| Total net carried claim and claim adjustment expense reserves | $ | 393 | $ | 357 | |||||||
60
Table of Contents
INVESTMENTS
Net Investment Income
The significant components of Net investment income are presented in the following table. Fixed income securities, as presented, include both fixed maturity securities and non-redeemable preferred stock.
| Periods ended September 30 | Three Months | Nine Months | |||||||||||||||||||||
| (In millions) | 2026 | 2025 | 2026 | 2025 | |||||||||||||||||||
| Fixed income securities: | |||||||||||||||||||||||
| Taxable fixed income securities | $ | 520 | $ | 506 | $ | 1,527 | $ | 1,510 | |||||||||||||||
| Tax-exempt fixed income securities | 55 | 44 | 162 | 114 | |||||||||||||||||||
| Total fixed income securities | 575 | 550 | 1,689 | 1,624 | |||||||||||||||||||
| Limited partnership and common stock investments | 48 | 71 | 221 | 225 | |||||||||||||||||||
| Other, net of investment expense | 12 | 17 | 36 | 55 | |||||||||||||||||||
| Net investment income | $ | 635 | $ | 638 | $ | 1,946 | $ | 1,904 | |||||||||||||||
| Effective income yield for the fixed income securities portfolio | 5.0 | % | 4.8 | % | 4.9 | % | 4.8 | % | |||||||||||||||
| Limited partnership and common stock return for the period | 1.5 | % | 2.5 | % | 7.3 | % | 8.3 | % | |||||||||||||||
Net investment income decreased $3 million for the three months ended September 30, 2026 as compared with the same period in 2025 driven by lower limited partnership returns, partially offset by higher income from fixed income securities as a result of a larger invested asset base and favorable reinvestment rates, as well as higher common stock returns.
Net investment income increased $42 million for the nine months ended September 30, 2026 as compared with the same period in 2025 driven by higher income from fixed income securities as a result of a larger invested asset base and favorable reinvestment rates as well as higher common stock returns, partially offset by lower limited partnership returns.
Net Investment (Losses) Gains
The components of Net investment (losses) gains are presented in the following table.
| Periods ended September 30 | Three Months | Nine Months | |||||||||||||||||||||
| (In millions) | 2026 | 2025 | 2026 | 2025 | |||||||||||||||||||
| Fixed maturity securities: | |||||||||||||||||||||||
| Corporate bonds and other | $ | 6 | $ | (6) | $ | (4) | $ | (55) | |||||||||||||||
| States, municipalities and political subdivisions | — | 1 | (1) | — | |||||||||||||||||||
| Asset-backed | (1) | (5) | (12) | (12) | |||||||||||||||||||
| Total fixed maturity securities | 5 | (10) | (17) | (67) | |||||||||||||||||||
| Non-redeemable preferred stock | (14) | 4 | (15) | 10 | |||||||||||||||||||
| Derivatives, short-term and other | (1) | (1) | (1) | — | |||||||||||||||||||
| Mortgage loans | 1 | — | 1 | (5) | |||||||||||||||||||
| Net investment losses | (9) | (7) | (32) | (62) | |||||||||||||||||||
| Income tax benefit on net investment losses | 2 | 1 | 8 | 13 | |||||||||||||||||||
| Net investment losses, after tax | $ | (7) | $ | (6) | $ | (24) | $ | (49) | |||||||||||||||
Pretax net investment losses increased $2 million for the three months ended September 30, 2026 as compared with the same period in 2025, driven by the unfavorable change in fair value of non-redeemable preferred stock partially offset by net gains on disposals of fixed maturity securities in the current period compared with net losses in the prior year period.
Pretax net investment losses decreased $30 million for the nine months ended September 30, 2026, as compared with the same period in 2025, driven by net gains on disposals of fixed maturity securities in the current period
61
Table of Contents
compared with net losses in the prior year period, as well as lower impairment losses, partially offset by the unfavorable change in fair value of non-redeemable preferred stock.
Further information on our investment gains and losses is set forth in Note C to the Condensed Consolidated Financial Statements included under Part I, Item 1.
Portfolio Quality
The following table presents the estimated fair value and net unrealized gains (losses) of our fixed maturity securities by rating distribution.
| September 30, 2026 | December 31, 2025 | ||||||||||||||||||||||
(In millions) | Estimated Fair Value | Net Unrealized Gains (Losses) | Estimated Fair Value | Net Unrealized Gains (Losses) | |||||||||||||||||||
| U.S. Government, Government agencies and Government-sponsored enterprises | $ | 3,225 | $ | (469) | $ | 3,274 | $ | (228) | |||||||||||||||
| AAA | 4,048 | (419) | 3,997 | (136) | |||||||||||||||||||
| AA | 7,404 | (998) | 7,001 | (428) | |||||||||||||||||||
| A | 10,720 | (753) | 11,167 | (140) | |||||||||||||||||||
| BBB | 14,791 | (1,087) | 16,249 | (223) | |||||||||||||||||||
| Non-investment grade | 1,879 | (155) | 1,714 | (42) | |||||||||||||||||||
| Total | $ | 42,067 | $ | (3,881) | $ | 43,402 | $ | (1,197) | |||||||||||||||
As of September 30, 2026 and December 31, 2025, 2% and 1% of our fixed maturity portfolio was rated internally. Additionally, as of September 30, 2026 and December 31, 2025, we assigned a AAA rating to $741 million and $661 million of municipal bonds that were either pre-refunded or backed by mortgage loans guaranteed by a U.S. government agency or sponsored enterprise.
The following table presents available-for-sale fixed maturity securities in a gross unrealized loss position by ratings distribution.
| September 30, 2026 | |||||||||||
| (In millions) | Estimated Fair Value | Gross Unrealized Losses | |||||||||
| U.S. Government, Government agencies and Government-sponsored enterprises | $ | 3,200 | $ | 469 | |||||||
| AAA | 3,437 | 448 | |||||||||
| AA | 6,113 | 1,062 | |||||||||
| A | 8,314 | 843 | |||||||||
| BBB | 12,137 | 1,181 | |||||||||
| Non-investment grade | 1,268 | 168 | |||||||||
| Total | $ | 34,469 | $ | 4,171 | |||||||
The following table presents the maturity profile for these available-for-sale fixed maturity securities. Securities not due to mature on a single date are allocated based on weighted average life.
| September 30, 2026 | |||||||||||
| (In millions) | Estimated Fair Value | Gross Unrealized Losses | |||||||||
| Due in one year or less | $ | 1,109 | $ | 14 | |||||||
| Due after one year through five years | 8,141 | 451 | |||||||||
| Due after five years through ten years | 9,618 | 1,027 | |||||||||
| Due after ten years | 15,601 | 2,679 | |||||||||
| Total | $ | 34,469 | $ | 4,171 | |||||||
62
Table of Contents
Duration
A primary objective in the management of the investment portfolio is to optimize return relative to the corresponding liabilities and respective liquidity needs. Our views on the current interest rate environment, tax regulations, asset class valuations, specific security issuer and broader industry segment conditions as well as domestic and global economic conditions, are some of the factors that enter into an investment decision. We also continually monitor exposure to issuers of securities held and broader industry sector exposures and may from time to time adjust such exposures based on our views of a specific issuer or industry sector.
A further consideration in the management of the investment portfolio is the characteristics of the corresponding liabilities and the ability to align the duration of the portfolio to those liabilities and to meet future liquidity needs, minimize interest rate risk and maintain a level of income sufficient to support the underlying insurance liabilities. For portfolios where future liability cash flows are determinable and typically long-term in nature, we segregate investments for asset/liability management purposes. The segregated investments support the long-term care and structured settlement liabilities in the Life & Group segment.
The effective durations of fixed income securities and short-term investments are presented in the following table. Amounts presented are net of payable and receivable amounts for securities purchased and sold, but not yet settled.
| September 30, 2026 | December 31, 2025 | ||||||||||||||||||||||
| (In millions) | Estimated Fair Value | Effective Duration (In years) | Estimated Fair Value | Effective Duration (In years) | |||||||||||||||||||
| Life & Group | $ | 14,181 | 9.8 | $ | 15,584 | 9.7 | |||||||||||||||||
| Property & Casualty and Corporate & Other | 30,042 | 4.6 | 30,716 | 4.5 | |||||||||||||||||||
| Total | $ | 44,223 | 6.3 | $ | 46,300 | 6.3 | |||||||||||||||||
The effective duration of investments supporting Life & Group liabilities at September 30, 2026 lengthened slightly as compared with December 31, 2025, reflecting recent portfolio actions to reduce reinvestment risk partially offset by the impact of the increase in interest rates during the period.
The investment portfolio is periodically analyzed for changes in duration and related price risk. Certain securities have duration characteristics that are variable based on market interest rates, credit spreads and other factors that may drive variability in the amount and timing of cash flows. Additionally, we periodically review the sensitivity of the portfolio to the level of foreign exchange rates and other factors that contribute to market price changes. A summary of these risks and specific analysis on changes is included in the Quantitative and Qualitative Disclosures About Market Risk included under Item 7A of our Annual Report on Form 10-K for the year ended December 31, 2025.
63
Table of Contents
LIQUIDITY AND CAPITAL RESOURCES
Cash Flows
Our primary operating cash flow sources are premiums and investment income. Our primary operating cash flow uses are payments for claims, policy benefits and operating expenses, including interest expense on corporate debt. Additionally, cash may be paid or received for income taxes.
For the nine months ended September 30, 2026, net cash provided by operating activities was $1,696 million as compared with $1,920 million for the same period in 2025. The decrease in cash provided by operating activities was driven by an increase in net claim payments partially offset by an increase in premiums collected.
Cash flows from investing activities include the purchase and disposition of financial instruments, excluding those held as trading, and may include the purchase and sale of businesses, equipment and other assets not generally held for resale.
For the nine months ended September 30, 2026, net cash used by investing activities was $752 million as compared with $1,446 million for the same period in 2025. Net cash used or provided by investing activities is primarily driven by cash available from operations and by other factors, such as financing activities.
Cash flows from financing activities may include proceeds from the issuance of debt and equity securities, and outflows for stockholder dividends, repayment of debt and purchases of our common stock.
For the nine months ended September 30, 2026, net cash used by financing activities was $1,001 million as compared with $478 million for the same period in 2025. Financing activities for the periods presented include:
•During the nine months ended September 30, 2026, we paid dividends of $943 million and repurchased 755,000 shares of our common stock at an aggregate cost of $36 million.
•During the nine months ended September 30, 2025, we paid dividends of $922 million and repurchased 700,000 shares of our common stock at an aggregate cost of $34 million.
•In the third quarter of 2025, we issued $500 million of 5.20% notes due August 15, 2035.
64
Table of Contents
Common Stock Dividends
Cash dividends of $3.44 per share on our common stock, including a special cash dividend of $2.00 per share, were declared and paid during the nine months ended September 30, 2026. On October 30, 2026, our Board of Directors declared a quarterly cash dividend of $0.48 per share, payable December 3, 2026 to stockholders of record on November 16, 2026. The declaration and payment of future dividends to holders of our common stock will be at the discretion of our Board of Directors and will depend on many factors, including our earnings, financial condition, business needs and regulatory constraints.
Liquidity
We believe that our present cash flows from operating, investing and financing activities are sufficient to fund our current and expected working capital and debt obligation needs and we do not expect this to change in the near term. There are currently no amounts outstanding under our $250 million senior unsecured revolving credit facility and no borrowings outstanding through our membership in the Federal Home Loan Bank of Chicago (FHLBC).
Dividends from Continental Casualty Company (CCC) are subject to the insurance holding company laws of the State of Illinois, the domiciliary state of CCC. Under these laws, ordinary dividends, or dividends that do not require prior approval by the Illinois Department of Insurance, are determined based on the greater of the prior year's statutory net income or 10% of statutory surplus as of the end of the prior year, as well as timing and amount of dividends paid in the preceding twelve months. Additionally, ordinary dividends may only be paid from earned surplus, which is calculated by removing unrealized gains from unassigned surplus. As of September 30, 2026, CCC was in a positive earned surplus position. CCC paid dividends of $905 million and $755 million to CNAF during the nine months ended September 30, 2026 and 2025. The actual level of dividends paid in any year is determined after an assessment of available dividend capacity, holding company liquidity and cash needs as well as the impact the dividends will have on the statutory surplus of the applicable insurance company.
We have an effective shelf registration statement on file with the Securities and Exchange Commission under which we may publicly issue an unspecified amount of debt, equity or hybrid securities from time to time.
65
Table of Contents
ACCOUNTING STANDARDS UPDATE
For a discussion of Accounting Standards, see Note A to the Condensed Consolidated Financial Statements included under Part I, Item 1.
FORWARD-LOOKING STATEMENTS
This report contains a number of forward-looking statements which relate to anticipated future events rather than actual present conditions or historical events. These statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 and generally include words such as “believes,” “expects,” “intends,” “anticipates,” “estimates” and similar expressions. Forward-looking statements in this report include any and all statements regarding expected developments in our insurance business, including losses and loss reserves (note that loss reserves for long-term care, A&EP and other mass tort claims are more uncertain, and therefore more difficult to estimate than loss reserves respecting traditional property and casualty exposures); the impact of routine ongoing insurance reserve reviews we conduct; our expectations concerning our revenues, earnings, expenses and investment activities; volatility in investment returns; and our proposed actions in response to trends in our business. Forward-looking statements, by their nature, are subject to a variety of inherent risks and uncertainties that could cause actual results to differ materially from the results projected in the forward-looking statements. We cannot control many of these risks and uncertainties. These risks and uncertainties include, but are not limited to, the following as well as those risks contained in the Risk Factors section of our 2025 Annual Report on Form 10-K:
Company-Specific Factors
•the risks and uncertainties associated with our insurance reserves, as outlined in the Critical Accounting Estimates sections of our 2025 Annual Report on Form 10-K and this report, and the Reserves - Estimates and Uncertainties section of our 2025 Annual Report on Form 10-K, including the sufficiency of the reserves and the possibility of future increases, which would be reflected in the results of operations in the period that the need for such adjustment is determined;
•the risk that the other parties to the transactions in which, subject to certain limitations, we ceded our legacy A&EP and excess workers' compensation (EWC) liabilities, respectively, will not fully perform their respective obligations to CNA, the uncertainty in estimating loss reserves for A&EP and EWC liabilities and the possible continued exposure of CNA to liabilities for A&EP and EWC claims that are not covered under the terms of the respective transactions; and
•the performance of reinsurance companies under reinsurance contracts with us.
Industry and General Market Factors
•general economic and business conditions, including potential recessionary conditions that may decrease the size and number of our insurance customers and create losses in our lines of business, and inflationary pressures on medical care costs, construction costs and other economic sectors;
•the effect of new tariffs and changes in tariffs, as well as significant uncertainty surrounding U.S. tariff policy generally, and any retaliatory tariffs, may adversely impact the economic environment, inflation expectations and certain loss costs, and may result in decreases in the size and number of our insurance customers;
•geopolitical tensions, including the effects of the conflict in the Middle East, that may adversely impact our operations;
•the effects of social inflation, including frequency of nuclear verdicts and increased litigation activity, on the severity of claims;
•the effects on the frequency of claims of reviver statutes that extend, or eliminate, the statute of limitations for the reporting of claims, including statutes passed in certain states with respect to sexual abuse;
•the impact of competitive products, policies and pricing and the competitive environment in which we operate, including changes in our book of business;
•product and policy availability and demand and market responses, including the level of ability to obtain rate increases;
•conditions in the capital and credit markets, including uncertainty and instability in these markets, as well as the overall economy, and their impact on the returns, types, liquidity and valuation of our investments;
66
Table of Contents
•conditions in the capital and credit markets that may limit our ability to raise significant amounts of capital on favorable terms or at all; and
•the possibility of changes in our ratings by ratings agencies, including the inability to access certain markets or distribution channels and the required collateralization of future payment obligations as a result of such changes, and changes in rating agency policies and practices.
Regulatory, Legal and Operational Factors
•regulatory and legal initiatives and compliance with governmental regulations and other legal requirements, which are increasing in complexity and number, change frequently, sometimes conflict, and could expose us to significant monetary damages, regulatory enforcement actions, fines and/or criminal prosecution in one or more jurisdictions, including regulations related to cybersecurity protocols (which continue to evolve in breadth, sophistication and maturity in response to an ever-evolving threat landscape) or utilization of artificial intelligence (AI), legal inquiries by state authorities, judicial interpretations within the regulatory framework, including interpretation of policy provisions, decisions regarding coverage and theories of liability, legislative actions that increase claimant activity, including those revising applicability of statutes of limitations, trends in litigation and the outcome of any litigation involving us and rulings and changes in tax laws and regulations;
•regulatory limitations, impositions and restrictions upon us, including with respect to our ability to increase premium rates, and the effects of assessments and other surcharges for guaranty funds and second-injury funds, other mandatory pooling arrangements and future assessments levied on insurance companies;
•regulatory limitations and restrictions, including limitations upon our ability to receive dividends from our insurance subsidiaries, imposed by regulatory authorities, including regulatory capital adequacy standards;
•additional complexities and greater risk to the effectiveness of controls with the incorporation of AI into our and our third-party service providers' operations, including the possibility of inaccurate or biased outputs, degradation in model performance, unauthorized use or disclosure of data used to train AI models, and the potential for AI to be misused to perpetrate fraud or evade monitoring controls; and
•breaches of our or our vendors' data security infrastructure resulting in unauthorized access to systems and information, and/or interruption of operations.
Impact of Natural and Man-Made Disasters and Mass Tort Claims
•weather and other natural physical events, including the severity and frequency of storms, hail, snowfall and other winter conditions, natural disasters such as hurricanes, tornados and earthquakes, as well as climate change, including effects on global weather patterns, greenhouse gases, sea, land and air temperatures, sea levels, wildfires, rain, hail and snow;
•regulatory requirements imposed by coastal state regulators in the wake of hurricanes or other natural disasters, including limitations on the ability to exit markets or to non-renew, cancel or change terms and conditions in policies, as well as mandatory assessments to fund any shortfalls arising from the inability of quasi-governmental insurers to pay claims;
•man-made disasters, including the possible occurrence of terrorist attacks, the unpredictability of the nature, targets, severity or frequency of such events, and the effect of the absence or insufficiency of applicable terrorism legislation on coverages;
•the occurrence of epidemics and pandemics; and
•mass tort claims, including those related to exposure to potentially harmful products or substances such as glyphosate, lead paint, per- and polyfluoroalkyl substances (PFAS) and opioids, sexual abuse and molestation claims and claims arising from changes in statutes of limitation and other changes that repeal or weaken tort reforms.
Our forward-looking statements speak only as of the date of the filing of this Quarterly Report on Form 10-Q and we do not undertake any obligation to update or revise any forward-looking statement to reflect events or circumstances after the date of the statement, even if our expectations or any related events or circumstances change.
67
Table of Contents
Item 3. Quantitative and Qualitative Disclosures About Market Risk
There were no material changes in our market risk components for the three months ended September 30, 2026. See the Quantitative and Qualitative Disclosures About Market Risk included in Item 7A of our Annual Report on Form 10-K for the year ended December 31, 2025 for further information. Additional information related to portfolio duration is discussed in the Investments section of our Management's Discussion and Analysis of Financial Condition and Results of Operations included in Part I, Item 2.
Item 4. Controls and Procedures
The Company maintains a system of disclosure controls and procedures which are designed to ensure that information required to be disclosed by the Company in reports that it files or submits to the Securities and Exchange Commission under the Securities Exchange Act of 1934, as amended (the “Exchange Act”), including this report, is recorded, processed, summarized and reported on a timely basis. These disclosure controls and procedures include controls and procedures designed to ensure that information required to be disclosed under the Exchange Act is accumulated and communicated to the Company's management on a timely basis to allow decisions regarding required disclosure.
As of September 30, 2026, the Company's management, including the Company's Chief Executive Officer (CEO) and Chief Financial Officer (CFO), conducted an evaluation of the effectiveness of the Company's disclosure controls and procedures (as such term is defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act). Based on this evaluation, the CEO and CFO have concluded that the Company's disclosure controls and procedures are effective as of September 30, 2026.
There has been no change in the Company’s internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) during the quarter ended September 30, 2026 that has materially affected, or is reasonably likely to materially affect, the Company’s internal control over financial reporting.
68
Table of Contents
PART II. Other Information
Item 1. Legal Proceedings
Information on our legal proceedings is set forth in Note G to the Condensed Consolidated Financial Statements included under Part I, Item 1.
Item 6. Exhibits
See Exhibit Index.
69
Table of Contents
SIGNATURES
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| CNA Financial Corporation | ||||||||
| Dated: November 2, 2026 | By | /s/ Scott R. Lindquist | ||||||
| Scott R. Lindquist Executive Vice President and Chief Financial Officer (Duly authorized officer and principal financial officer) | ||||||||
70
Table of Contents
EXHIBIT INDEX
| Description of Exhibit | Exhibit Number | ||||
Certification of Chief Executive Officer | 31.1 | ||||
Certification of Chief Financial Officer | 31.2 | ||||
Written Statement of the Chief Executive Officer of CNA Financial Corporation Pursuant to 18 U.S.C. Section 1350 (As adopted by Section 906 of the Sarbanes-Oxley Act of 2002) | 32.1 | ||||
Written Statement of the Chief Financial Officer of CNA Financial Corporation Pursuant to 18 U.S.C. Section 1350 (As adopted by Section 906 of the Sarbanes-Oxley Act of 2002) | 32.2 | ||||
| XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document | 101.INS | ||||
| Inline XBRL Taxonomy Extension Schema | 101.SCH | ||||
| Inline XBRL Taxonomy Extension Calculation Linkbase | 101.CAL | ||||
| Inline XBRL Taxonomy Extension Definition Linkbase | 101.DEF | ||||
| Inline XBRL Taxonomy Label Linkbase | 101.LAB | ||||
| Inline XBRL Taxonomy Extension Presentation Linkbase | 101.PRE | ||||
| Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101) | 104.1 | ||||
71